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ABSTRACT 
 
Ergot alkaloid biosynthesis in Aspergillus fumigatus: Association with sporulation 
and clustered genes common among ergot fungi 
 
Christine M. Coyle 
 
Ergot alkaloids, indole-derived mycotoxins, interact with multiple monoamine 
neurotransmitter receptors and cause disease in exposed individuals.  They have been 
well studied in the ergot fungus, Claviceps purpurea, and have been reported in some 
closely related grass endophytes, as well as the distantly related opportunistic human 
pathogen Aspergillus fumigatus.  A. fumigatus, which sporulates prolifically, produces 
clavines, specifically festuclavine and fumigaclavines A, B, and C in association with 
asexual spores and the total mass of alkaloids constitutes over 1% of the spore mass.  
These alkaloids differ from those of most clavicipitaceous fungi, which consist of 
different clavines and often more complex lysergic acid derivatives.  However, the ergot 
alkaloid pathways of A. fumigatus and ergot fungi are hypothesized to share early 
biosynthetic steps, diverging at some point after the formation of the intermediate 
chanoclavine.  A homologue of dmaW, a gene encoding dimethylallyltryptophan synthase 
in Neotyphodium endophytes, was found in the A. fumigatus genome.  By gene knockout 
analysis, dmaW was shown to be required for ergot alkaloid production in A. fumigatus.  
Comparison of genes clustered around A. fumigatus dmaW to those clustered with dmaW 
in the ergot fungi revealed potential homologues that could encode proteins controlling 
early, shared steps in the pathway.  Functional analysis via gene knockout of three 
additional A. fumigatus genes (easA, easE, and easF) rendered mutants with altered 
alkaloid profiles, demonstrating their involvement in ergot alkaloid biosynthesis.  All 
mutants lacked normal ergot alkaloid production from the latter part of the pathway; 
complementation with a functional copy of the respective gene, restored normal ergot 
alkaloid production in each mutant.  Analyses of intermediates positioned the products of 
easF and easE as the second and third enzymatic steps of the pathway.  Knockout of 
easA caused accumulation of multiple intermediates, including chanoclavine; 
complementation with the C. purpurea easA gene resulted in accumulation of 
agroclavine, setoclavine, and its isomer isosetoclavine.  These data confirm easA 
involvement post chanoclavine synthesis and more specifically assign its role to 
reduction of chanoclavine aldehyde, the branch point of the two lineage-specific 
pathways.  These mutants, due to their differing ergot alkaloid profiles, are valuable for 
testing the role of specific ergot alkaloids in animal pathogenesis and toxicoses.  
Elucidation of ergot alkaloid biosynthesis, along with the capacity to control the spectrum 
of alkaloids produced, may be beneficial to agriculture and medicine.  Additional studies 
demonstrated that production of ergot alkaloids was restricted to conidiating cultures.  
Disruption of brlA, a regulatory gene involved in conidiation, interfered with 
conidiophore development, as well as ergot alkaloid production.  The association of these 
toxins with sporulation may offer insight into their ecological significance and utility to 
the fungus. 
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REVIEW OF LITERATURE 
OVERVIEW  
Ergot alkaloids are mycotoxins that can cause ill effects in humans and animals; however, 
the medical community has also found advantageous uses for these compounds as 
treatments for some diseases and other clinical conditions.  They were first discovered in 
the sclerotia of the ergot fungus, Claviceps purpurea.  Ingestion of grain contaminated 
with ergot sclerotia causes ergotism (44).  Ergot alkaloids have been extensively studied 
in C. purpurea, although the pathway by which ergot alkaloids are synthesized has yet to 
be fully determined (21, 57).  Ergot alkaloids also have been reported in other species, 
such as Neotyphodium spp. which are endophytes of grasses, Penicillium spp. and 
Aspergillus fumigatus (15, 30).  A. fumigatus is a common fungus found in a variety of 
indoor environments, including ventilation systems, and generates airborne spores that 
are a potential danger to the health of humans.  The spores can embed and survive in the 
lungs of humans and animals, causing ill health to the affected individual and significant 
lung disease in immunocompromised persons.  Whether ergot alkaloids contribute to the 
virulence of the fungus or cause toxicoses in the absence of fungal colonization is 
unknown.   
ERGOT ALKALOIDS AND THEIR HISTORICAL SIGNIFICANCE 
Ergot alkaloids are a family of indole-derived mycotoxins that were first discovered in 
the ergot fungus, Claviceps purpurea and are known to cause a wide range of effects on 
exposed individuals due to their nonselective interactions with several monoamine 
neurotransmitter receptors.  Unnecessary for the survival of the fungus, at least under 
laboratory conditions, these secondary metabolites clearly impact individuals that 
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consume them.  Typically these metabolites affect the central nervous, circulatory, 
immune, and reproductive systems (20, 42, 47, 58).  In mammals, they can act as agonists 
and/ or antagonists of dopamine, 5-hydroxytryptamine (5-HT; serotonin), and 
noradrenaline (norepinephrine) receptors (46, 47).  The severity to which humans and 
animals are affected is dependent upon multiple factors such as the toxicity of the 
particular ergot alkaloid, exposure time, and the health status of the individual.  In the 
past, people ingested elevated amounts of ergot alkaloids through consumption of grain 
contaminated with sclerotia of the ergot fungus, C. purpurea (44), which led to ergotism, 
a condition then known as St. Anthony’s fire.  Exposure to alkaloids can cause 
hallucinations, gangrene, and even death.  It has been hypothesized that these toxins were 
responsible for the Salem witch trials in Massachusetts in the seventeenth century (50).   
Different types of alkaloids affect the clinical manifestations of ergotism.  
However, there is significant overlap in the types of symptoms induced by different ergot 
alkaloid sources.  Ergopeptine alkaloids such as ergotamine or ergocristine, peptide 
derivatives of lysergic acid, are frequently associated with a gangrenous form of ergotism 
due to their vasoconstrictive activity.  They cause painful edema of the legs and gangrene 
at the tendons.  The last documented outbreak of this form of ergotism was seen in 
Ethiopia in 1977-1978 where 34% of the affected individuals died.  Ergotism due to 
intoxication with ergot clavines or simple amides of lysergic acid is more typically 
associated with a convulsive form of ergotism.  Affected individuals experience 
gastrointestinal symptoms as well as problems within their central nervous system.  The 
last documented outbreak of ergotism due to ergot clavines was seen in India in 1975.  
All affected individuals survived (44).  Today, ergotism in humans is a rare occurrence 
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due to grain cleaning before milling which removes most of the sclerotia; however, it is 
still a major concern for animal husbandry of domestic animals, such as cattle, horses, 
sheep, pigs, and chickens, which feed on contaminated grasses or grains (1, 16).   
Lambs fed a diet containing endophyte infected fescue seed (E+) showed a linear 
reduction in feed intake, skin temperature, thermocirculation index (TCI), and prolactin 
concentration when fed diets rich in E+ (17).  Prolactin concentration was significantly 
lowered by E+ intake, presumably due to the presence of ergot alkaloids.  
Supplementation of feed with ergovaline caused a similar effect, but not to the same 
extent as E+, suggesting that the other ergot alkaloids also play a role in toxicoses.  In a 
different study, ergovaline and lysergic acid could be detected in ruminal fluid, urine 
(lysergic acid only), and feces in lambs fed an E+ diet (10).   
Research has shown cattle that graze E+ tall fescue have lowered average daily 
weight gains, increased body temperatures, rough coats, lowered prolactin production, 
and reduced conception rates (16).  Cattle grazing on mixed grasses containing E+ and E- 
showed intermediate weight gain compared to cattle that grazed E- only and E+ only 
pastures.  A Norwegian study reported the occurrence of ergotism in free-living moose 
and roe deer that fed on wild grasses (23).  Ergocristine was the major alkaloid found 
among the sampled wild grasses; this ergopeptine alkaloid, along with other unknown 
alkaloids, could account for the gangrenous symptoms in the wild Norwegian cervids 
(61).  Ergot alkaloids have also been shown to affect rabbits, insects, and bacteria (6, 12, 
37, 42, 48, 49). 
Because of their high affinity for neurotransmitter receptors, there are also 
advantageous effects of alkaloid consumption.  The medical community uses these 
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compounds as a treatment for migraines, and they are also effective against Parkinsonism 
and to induce uterine contractions in childbirth (26).  However, because of their lack of 
specificity for individual neurotransmitter receptors, negative side effects limit the utility 
of these drugs (30, 42).  During the twentieth century, a Swiss chemist named Albert 
Hofmann began creating semi-synthetic ergot alkaloids.  Among his many concoctions, 
arose two important drugs, Methergine, which was responsible for preventing 
hemorrhage after childbirth, and lysergic acid diethylamide (LSD), a hallucinogenic drug 
used by psychiatrists and the CIA, as well as a popular recreational drug of the 60’s and 
early 70’s (1).  Use of LSD or dihydroergotamine has been known to cause a condition 
known as serotonin syndrome, which is a condition that shares similar clinical features 
with convulsive ergotism (11, 18).   
CLASSES OF ERGOT ALKALOIDS 
Ergot alkaloids are often characterized as clavines, simple amides of lysergic acid or 
ergopeptines (Fig. 1).  Clavines are precursors of lysergic acid; whereas both simple 
amides and ergopeptines, non-ribosomally synthesized peptides, are derivatives of 
lysergic acid (41, 51).  Ergot alkaloids are derivatives of tryptophan, and the majority of 
them contain ergoline, a tetracyclic ring structure, as the basic structure, with methylation 
at N-6.  Modifications at the C-8 position, double bonds between carbon 8 and 9 or 9 and 
10, and opening of ring D are various ways ergot alkaloids differ, causing them to have 
different chemical properties (29).  Substitutions at C-8 separate ergot alkaloids into the 
three different classes (15)(Fig.1).  Clavines are the simplest of the ergot alkaloids.  
Typically, clavines have a methyl or hydroxymethyl group attached to the C-8 of the 
ergoline; however some have a carbonyl group at this site (29).    Chanoclavine and 
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members within the subclass 6,7-secoergolines have an open D ring, which differentiates 
them from other clavines.  Clavines are the ultimate end products of the ergot alkaloid 
pathway in some fungi (e.g., Claviceps fusiformis and A. fumigatus); however, they 
accumulate in other ergot alkaloid-producing fungi as products of shunts off the pathway 
or are intermediates to more complex ergot alkaloids.  Besides causing toxicoses in 
exposed individuals, clavines also affect food preference by acting as a deterrent in rabbit 
feeding in experiments using endophyte infected grasses (37). 
Simple amides of lysergic acid include lysergic acid amide (ergine), ergonovine, 
lysergic acid-2-hydroxyethylamide, and lysergyl alanine.  The observation that lysergyl 
peptide synthetase 1 is required for synthesis of ergine and lysergyl alanine suggests that 
these simple amides are by-products of ergopeptine synthesis (43).  However, in some 
cases simple amides accumulate as the ultimate product of the ergot alkaloid pathways, 
such as ergine and lysergic acid-2-hydroxyethyl amide in C. paspali.   
Ergopeptines, the most complex ergot alkaloids, have three amino acids attached 
to D-lysergic acid.  Biosynthesis of ergopeptines requires a peptide synthetase complex to 
catalyze the peptide bonds between the amino acids and lysergic acid.  Most of the 
variation in ergopeptines comes from the differences in amino acids that occupy positions 
I and II of the tripeptide chain attached to lysergic acid (Fig. 2).  Proline typically 
occupies amino acid position III; the sole exception being the presence of alanine at this 
position in ergobalansine (29).  Ergopeptines can be divided into three subclasses: the 
ergotamine group, ergotoxine group, and ergoxine group; classification is dependent on 
the amino acid present in position I of the peptide.  Individual ergot alkaloids within 
subclasses differ in the amino acid residing in position II.  Possible amino acids 
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occupying this position are phenylalanine, leucine, isoleucine, norleucine, valine, 
methionine and alpha-amino butyric acid (51).  Ergovaline is a major alkaloid found 
within Neotyphodium spp., whereas ergosine and ergotamine are examples of abundant 
ergopeptine within Claviceps spp. (34, 36).  
Ergopeptams, also known as lactam ergot alkaloids, are non-cyclol ergopeptines, 
due to the lack of hydroxylation of the amino acid in position I; hence a cyclol bridge is 
unable to form.  The proline in these alkaloids is in D-configuration (15, 29).  
Ergopeptams are further characterized into the subclasses, ergotamams, ergoxams, 
ergotoxams, and ergoannams. 
ERGOT ALKALOID PRODUCING FUNGI 
Claviceps and the Neotyphodium endophytes (42, 51) are clavicipitaceous genera 
belonging to the order Hypocreales.  Claviceps spp. parasitize flowers of rye and other 
cereals; sclerotia, fungal overwintering bodies, replace the infected plant host’s seeds.  
Ergot alkaloid-rich sclerotia may be harvested along with the grain, and so grain cleaning 
is essential to eliminate toxicoses.  Neotyphodium spp. and their teleomorphs, Epichloë 
spp., are endophytes of cool-season grasses, such as tall fescue and perennial ryegrass 
(51).  These fungi live symbiotically with their host species, grow intercellularly within 
the plant, and disseminate in seeds (15, 41).  The fungus provides many benefits to its 
host, such as drought tolerance and protection from pests.  However, the animals that 
graze on these E+ grasses are susceptible to toxicoses due to mycotoxin production (16, 
35, 48).  Ergot alkaloids are typically found in the pseudostems and leaf blades of these 
forages but are either undetectable or only found in extremely low concentrations 
(relative to pseudostem) within the roots (40, 41).  These clavicipitaceous fungi have the 
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capacity to biosynthesize a wide spectrum of alkaloids, especially lysergic acid amides 
and ergopeptines (42, 51).  However, due to the slow growth of these fungi and their 
dependency on their plant hosts for reliable production of alkaloids, biochemical and 
molecular aspects of the pathway have been elucidated slowly (39, 63).   
Several other species, besides those within the genera Claviceps and 
Neotyphodium, produce ergot alkaloids.  These include species within the genera 
Aspergillus  and Penicillium, which are common fungi in the order Eurotiales (30).  
These fungi produce only the clavine class of ergot alkaloids.  Among these is A. 
fumigatus, a thermotolerant opportunistic pathogen.  This fungus is capable of growing at 
temperatures up to 55 ºC and surviving at 70 ºC.  It colonizes domestic and public 
buildings, increasing exposure by humans (31).  The fungus grows in moist areas, such as 
basements and ventilation system ducts; it also is ubiquitous outdoors, with higher 
concentrations in areas surrounding compost and waste removal facilities.  The conidia 
(asexual spores) can become airborne and inhaled by humans and animals, which can 
infect and cause disease, act as an allergen, cause toxicoses, or cause inflammatory 
responses (13).  Contamination of ventilation systems with A. fumigatus in hospitals 
poses a serious threat to immune-deficient individuals of acquiring aspergillosis.  For the 
general population, a common question is: are indoor molds truly causing a “new” 
disease and if so, why is this more of an issue today than in the past?  Many studies 
correlate disease with indoor air quality, specifically regarding mold concentrations, in 
buildings and homes.  However, many of these claims have insufficient evidence and 
lack consistent clinical diagnoses.  Future studies need to correct the flaws of past 
research to address these questions (56).  
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Ergot alkaloid producers within Aspergillus and Penicillium produce clavine ergot 
alkaloids exclusively (30).  Aspergillus fumigatus accumulates four ergot alkaloids at 
relatively high levels: festuclavine and fumigaclavines A, B, and C (7, 54, 64) (Fig. 3).  
Many Claviceps spp. and Neotyphodium spp. are known to produce clavines, simple 
amides of lysergic acid and ergopeptines; however, not all species have the capability to 
synthesize all three classes, such as C. fusiformis, which produces only clavines (15, 51). 
The ergot alkaloid pathway is inefficient, allowing accumulation of both 
intermediates and end products (36).  Production of a wide spectrum of alkaloids could 
protect the fungus via deterrence of herbivores.  Panaccione et al. (37) showed clavines to 
be a greater deterrent to rabbit feeding than are ergopeptines.  However, ergovaline, an 
ergopeptine, caused a decrease in appetite.  This occurrence is supported by ergovaline’s 
ability to act as an agonist of 5HT2A, which is known to lower appetite (52).  Also, 
ergopeptines and/or lysergic acid amides deterred feeding of black cutworm on 
endophyte-infected grasses (49).  Together these studies show benefits associated with 
inefficiency in the ergot alkaloid pathway.   
ERGOT ALKALOID SYNTHESIS GENE CLUSTERS 
Typically, genes controlling the production of secondary metabolites are clustered within 
fungal genomes.  The driving force behind this phenomenon is unclear.  Some theories 
presented as explanations of this occurrence are that clustering of pathway genes 
facilitates horizontal transfer of the pathway, specifically the selfish cluster hypothesis 
(62), and that clustering allows coregulation of the secondary metabolite gene cluster 
(28).  The selfish gene hypothesis suggests that genes lacking beneficial qualities to their 
host persist via horizontal transmission (32).  The “selfish cluster” hypothesis takes this 
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concept one step further stating that clusters exist because they possess a selective 
advantage over the alternative situation in which the genes are dispersed in the genome 
(62).  This advantage is independent of any selective advantage as a result of the product 
biosynthesized by the genes of the cluster.  This commentary suggests that not only is the 
secondary metabolite pathway under selective pressure, but there is also selective 
pressure acting on the maintenance of the gene cluster arrangement at a subgenomic 
level.  Horizontal transmission could potentially drive the clustering of genes and seems 
to be more prevalent in eukaryotes with more accessible genomes, such as fungi (19, 32, 
62).   
Since the biosynthesis of secondary metabolites often is regulated by trans-acting 
factors, coregulation by cis-acting factors may not seem like a plausible cause for 
clustering.  However, by means of regulating the chromatin environment, coregulation 
could possibly be a driving force of clustering.  LaeA, a nuclear protein found in 
filamentous fungi, transcriptionally regulates gene clusters; it is thought to act as a 
methyltransferase capable of regulating transcription of clustered genes via modifying 
chromatin structure in the cluster (3).  Since clustering is a characteristic of secondary 
metabolite genes, LaeA, could be considered a global regulator of secondary metabolism 
in filamentous fungi, such as Aspergillus spp. (2, 3).  LaeA regulates the 
sterigmatocystin, penicillin, and terrequinone A gene clusters in A. nidulans and gliotoxin 
and ergot alkaloid gene clusters in A. fumigatus (2, 45).  
Ergot alkaloid biosynthesis genes are clustered in all of the fungi studied to date 
(21).  Dimethylallyltryptophan (DMAT) synthase catalyzes the determinant step of the 
ergot alkaloid biosynthesis pathway by forming DMAT from tryptophan and 
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dimethylallylpyrophosphate (63).  The gene dmaW encodes this enzymatic step, as 
determined by expression analyses of the C. fusiformis gene in yeast (57) and by gene 
knockout in Neotyphodium sp. (63).   
Another gene involved in the clavicipitaceous pathway, lpsA, a neighboring gene 
of dmaW in the Claviceps genome, was functionally analyzed by gene knockout in 
Neotyphodium sp. Lp1 (39).  Structural analysis of lpsA indicates similarities in 
sequences within modules correspond with same amino acid substrate within certain 
positions of the polypeptide, whereas sequences that lack similarity correspond with the 
addition of different amino acids within those positions (9, 21).  Neotyphodium 
coenophialum has two different copies of lpsA, which corresponds to it being a hybrid of 
multiple species (9).  Biochemical characterization of the lpsA knockout resulted in 
placing ergine and lysergyl-alanine after lysergyl peptide synthetase in ergot alkaloid 
biosynthesis (43).   
A second peptide synthetase, encoded by lpsB, plays a role in ergopeptine 
synthesis, based on knockout analysis in C. purpurea (8) and in N. lolii (14).  Fleetwood 
et al. (14) found evidence to support the presence of transposons within the N. lolii ergot 
alkaloid synthesis (eas) cluster.  The eas genes are highly expressed in planta, but were 
minimally expressed or undetectable in culture (14).   
CloA in C. purpurea is responsible for bridging two classes of ergot alkaloids, 
converting clavines (elymoclavine) to D-lysergic acid (22).  Since C. fusiformis and C. 
purpurea have different ergot alkaloid profiles, genomic comparison of the eas gene 
cluster between these species was performed to determine the genetic differences 
responsible for the corresponding chemotypes.  Both clusters contain nine eas gene 
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homologues, including cloA and lpsB, both of which are involved in biosynthesis of 
ergopeptines.  All nine eas genes were expressed in C. fusiformis.  However, CloA and 
LpsB were enzymatically inactive, and therefore C. fusiformis is unable to convert 
clavines to ergopeptines (33). These genes involved in ergot alkaloid biosynthesis are 
clustered in the genome of C. purpurea (21, 59).  Several additional genes clustered 
around dmaW, lpsA, lpsB, and cloA have functions typical of genes involved in secondary 
metabolism.   
SECONDARY METABOLISM AND SPORULATION 
There is an apparent association between morphological differentiation and secondary 
metabolism in microorganisms (5, 25).  Hopwood (25) demonstrated that sporulation and 
secondary metabolite biosynthesis in the filamentous bacterium, Streptomyces coelicolor 
A3, was translationally regulated by bldA, a gene that encodes for a tRNA corresponding 
to a leucine codon.  The mRNA involved in vegetative growth does not require this 
codon during translation, but it is essential for formation of proteins responsible for 
differential growth and antibiotic synthesis.  Typically in fungi, secondary metabolites 
associate with sporulation either as activators of sporulation, pigments necessary for 
sporulation structures, or as toxic metabolites whose production coincides with 
sporulation in the growing organism (5).  Environmental conditions are similar for 
secondary metabolite synthesis and sporulation; environmental factors such as, pH, 
temperature, air-surface interface, and nutrient supply have been found to regulate both 
sporulation and secondary metabolite production in Aspergillus spp. (5).   
Studies functionally analyzing genes regulating sporulation also have indicated a 
corresponding involvement in mycotoxin production in fungi.  In Aspergillus spp., 
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asexual sporulation and mycotoxin biosynthesis are regulated by a common G-protein 
signaling pathway (4).  In A. nidulans, FadA is responsible for vegetative growth through 
activation of cyclic AMP-dependent protein kinase A (PkaA).  FadA activation or knock 
out of flbA inhibits the production of conidia and sterigmatocystin (ST), a precursor of 
aflatoxin biosynthesis (24).  In the presence of FlbA, the FadA pathway is inhibited, at 
least partially, which allows ST synthesis and asexual sporulation to occur.  FlbA is a 
protein with a RGS (Regulator of G protein Signaling) domain.  Proteins in this family 
negatively regulate G-protein mediated pathways (24).  Mutations in the sec gene within 
A. parasiticus greatly reduce conidiophore production, and also eliminate aflatoxin 
biosynthesis and expression of aflR, a regulatory gene involved in the aflatoxin pathway 
(27).  Knockout analysis of the regulatory gene, stuA, in A. fumigatus again demonstrates 
the relationship between conidiation and secondary metabolism.  The transcription factor, 
StuAp, is responsible for proper conidiophore development and regulation of potentially 
six secondary metabolite clusters, one being ergot alkaloid biosynthesis (53, 60).  This 
result exemplifies the apparent association between sporulation and secondary 
metabolism, both of which are governed by a complex regulatory pathway.   
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ERGOT ALKALOIDS IN ASPERGILLUS FUMIGATUS 
Spilsbury and Wilkinson (55) were the first to document production of the ergot alkaloid, 
festuclavine, in A. fumigatus.  They also characterized two novel festuclavine derivatives, 
fumigaclavines A and B, produced by this fungus.  Soon after, Yamano et al. (64) noted 
an additional ergot alkaloid, fumigaclavine C, was also synthesized by A. fumigatus.  
Years later, Cole et al. (7) further characterized fumigaclavine C using broth cultures of 
A. fumigatus that had been isolated from moldy silage. 
More recently Panaccione and Coyle (38) demonstrated that A. fumigatus 
accumulates ergot alkaloids in association with its asexual spores (conidia), although 
exact location has not been discerned.  Accumulated ergot alkaloids were fumigaclavine 
C, festuclavine, fumigaclavine A, and fumigaclavine B in the order of abundance 
(Appendix 1, Table 2).  Under environmentally relevant conditions, the total mass of 
ergot alkaloids often exceeded 1% of the mass of a conidium.  Extraction of ergot 
alkaloids from conidia of A. fumigatus cultured on various media, revealed that extracts 
from cultures grown on latex paint or cultured maize seedlings accumulated the greatest 
quantities of ergot alkaloids.  Important physical attributes of conidia likely to affect their 
respirability, i.e. diameter, mass, and specific gravity, were significantly lower in A. 
fumigatus when compared to Aspergillus nidulans, Aspergillus niger, and Stachybotrys 
chartarum (Appendix 1, Table 1).   
OBJECTIVES AND POTENTIAL IMPACT OF CURRENT STUDY 
In efforts to further understand ergot alkaloid biosynthesis, the objectives of this study are 
to: 
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1. Characterize the ergot alkaloids produced by A. fumigatus, complete a structural 
analysis of the genes within the pathway 
2. Functionally analyze ergot alkaloid synthesis genes via gene knockouts, 
determine the spectrum of ergot alkaloids produced by each mutant strain and 
compare it to the production of the wild type 
3. Investigate the association of sporulation and ergot alkaloid production in A. 
fumigatus.   
 Several of the early steps in ergot alkaloid biosynthesis are just hypothesized and 
through this investigation they may be characterized experimentally.  Analysis of the 
gene cluster in A. fumigatus will aid in identifying genes involved in ergot alkaloid 
production in other species, especially genes involved in the early steps of the pathway 
thought to be shared by multiple species.  Ergot alkaloids are important metabolites in 
agriculture and medicine.  These metabolites possess a number of beneficial qualities, 
despite their many negative side effects.  Characterization of the ergot alkaloid pathway 
and the ability to control the spectrum of alkaloids produced may lead to advances in 
these fields by providing a potential means of eliminating the negative side effects.  
Likewise, production of alkaloids could be associated with cause of illness when A. 
fumigatus infects an individual.  Mutant strains developed from this research could be 
used for testing effects of ergot alkaloids on virulence and determining their role in 
mycoses and mycotoxicoses. 
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FIGURE LEGENDS 
Figure 1:  Representatives of the three classes of ergot alkaloids.  Festuclavine 
exemplifies clavine ergot alkaloids, ergine is a simple amide of lysergic acid and 
ergotamine represents ergopeptines.  One major difference between these classes is the 
substitution on C-8 (blue) and location of the double bond (red).  The letters, A-D, 
labeled within ergine, identify the four rings common to ergot alkaloids.  The atoms 
within this four ring structure are numbered 1-15 within ergine. 
 
Figure 2:  Amino acids involved in ergopeptine synthesis.  Ergopeptines are 
synthesized by addition of three amino acids onto D-lysergic acid.  Typically, proline is 
one of the three amino acids, therefore differentiation between the ergopeptines is due to 
the specific amino acids that occupy positions R1 and R2.  The chart shows the amino 
acids involved in assembly of six common ergopeptines.   
 
Figure 3:  Overview of hypothesized ergot alkaloid pathways of A. fumigatus (red 
branch) and clavicipitaceous fungi (blue branch).  Festuclavine, and fumigaclavine A, 
B, and C accumulate in A. fumigatus, with fumigaclavine C being the ultimate product.  
DMAPP = dimethylallylpyrophosphate; PPO = pyrophosphate; Trp = tryptophan;  
DMAT = dimethylallyltryptophan. 
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CHAPTER 1: An ergot alkaloid biosynthesis gene and clustered 
hypothetical genes from Aspergillus fumigatus 
 
Published as: Coyle, C. M., and D. G. Panaccione.  2005.  Appl. Environ. Microbiol. 71:3112–3118. 
 
ABSTRACT 
Ergot alkaloids are mycotoxins that interact with several monoamine receptors, 
negatively affecting cardiovascular, nervous, reproductive, and immune systems of 
exposed humans and animals.  Aspergillus fumigatus, a common airborne fungus and 
opportunistic human pathogen, contains at least four ergot alkaloids associated with its 
conidia.  The A. fumigatus genome contains a gene encoding dimethylallyltryptophan 
(DMAT) synthase, the enzyme that catalyzes the first committed step in ergot alkaloid 
biosynthesis.  Knockout of the DMAT synthase gene eliminated the ergot alkaloids from 
conidia, and complementation of the mutation restored ergot alkaloid production.  
Clustered with the DMAT synthase-encoding gene are sequences corresponding to five 
genes previously proposed to encode steps in the ergot alkaloid pathway of Claviceps 
purpurea, as well as additional sequences whose deduced protein products are consistent 
with involvement in the ergot alkaloid pathway.  The data indicate a common, but 
ancient, origin of ergot alkaloid biosynthetic capability with the ergot alkaloid producers 
in the distantly related Clavicipitaceae.   
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INTRODUCTION 
Ergot alkaloids are a complex family of indole-derived mycotoxins with varied and 
significant biological activities (6, 7, 14, 25).  Fungi derived from two relatively 
divergent ascomycete orders (Hypocreales and Eurotiales) produce ergot alkaloids.  
Several fungi in the family Clavicipitaceae (order Hypocreales) including the ergot fungi 
in the genus Claviceps and certain grass endophytes in the genera Epichloë (including 
their imperfect relatives in the genus Neotyphodium) and Balansia produce ergot 
alkaloids in association with their grass hosts (3, 6, 7, 14, 25).  The rather distantly 
related imperfect fungus Aspergillus fumigatus, a common saprophyte and opportunistic 
human pathogen with close relatives in the order Eurotiales, produces ergot alkaloids in 
broth culture (4, 23) and in association with its airborne conidia (13).   
Ergot alkaloid-producing members of the Clavicipitaceae (clavicipitaceous fungi) 
produce a wide variety of clavine and lysergyl-derived ergot alkaloids but commonly 
accumulate ergopeptines (nonribosomally synthesized peptides containing lysergic acid 
and three amino acids) or simple amides of lysergic acid such as ergine and ergonovine 
(6, 7, 8, 14).  Aspergillus fumigatus produces several clavine ergot alkaloids including 
festuclavine and fumigaclavines A, B, and C (4, 13, 23).  Most of the clavine and 
lysergyl-derived ergot alkaloids contain the same four-membered ergoline ring system 
but differ in the number, type, and position of side chains (6, 7, 8, 14).   
Festuclavine, one of the ergot alkaloids produced by A. fumigatus, was first 
described from C. purpurea (6, 7) and also has been detected in Neotyphodium spp. (15, 
19).  However, none of the fumigaclavines produced by A. fumigatus has been detected in 
a member of the Clavicipitaceae.  Likewise the end products of the Claviceps spp. and 
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Neotyphodium spp. pathways (ergopeptines and lysergic acid amides) have not been 
found in A. fumigatus.  This distribution of alkaloids is consistent with a hypothesis that 
early steps of the ergot alkaloid pathway are shared by these diverse fungal species but 
that the later portions of the pathway differ between A. fumigatus and the clavicipitaceous 
fungi.   
The ergot alkaloid pathway is relatively long and may have alternate branches or 
spurs in some ergot alkaloid producers (7, 8, 14, 15).  Functions of three genes involved 
in the ergot alkaloid pathway have been demonstrated by gene knockout.  The gene 
(dmaW) encoding dimethylallyltryptophan synthase (DMAT synthase) was knocked out 
in Neotyphodium sp. Lp1, an endophyte of perennial ryegrass (29).  Loss of all ergot 
alkaloids in this knockout mutant indicated that dmaW controls the determinant step in 
the ergot alkaloid pathway.  A gene encoding lysergyl peptide synthetase 1 (LPS1), one 
of two components of the lysergyl peptide synthetase complex responsible for assembly 
of ergopeptines from lysergic acid and three amino acids (20, 28), was knocked out in 
Neotyphodium sp. Lp1 (16).  LPS1-deficient knockout mutants failed to produce 
ergopeptines and simple amides of lysergic acid but still produced clavine ergot alkaloids 
(15, 16).  A gene encoding lysergyl peptide synthetase 2 (LPS2), the lysergic acid-
activating component of the lysergyl peptide synthetase complex, has been cloned and 
knocked out in C. purpurea, resulting in the loss of ergopeptines from the knockout 
mutant (5).  
Genes encoding DMAT synthase, LPS1, and LPS2 are clustered within ~32 kb of 
each other in the genome of C. purpurea (5, 25).  Moreover, at least six additional genes 
that encode activities likely to be required for ergot alkaloid production are interspersed 
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in this cluster with the ergot alkaloid biosynthesis genes (5, 25, 26).  Analysis of mRNAs 
from five of the clustered genes indicate they are expressed in cultures grown under 
conditions conducive to ergot alkaloid production but not under repressive conditions (5).  
Such clustering and common regulation of secondary metabolite biosynthetic pathway 
genes is typical of fungal genomes (9, 27).   
Our objective in this study was to investigate whether the ergot alkaloids of A. 
fumigatus share a common biosynthetic origin with those of the clavicipitaceous fungi by 
identification and functional analysis of the gene (dmaW) controlling the determinant step 
in the pathway and through comparison of sequences flanking dmaW in A. fumigatus and 
C. purpurea.   
MATERIALS AND METHODS 
Fungi and culture conditions.  Aspergillus fumigatus isolate WVU1943 from parakeet 
lung was described previously (13) and was manipulated in a class II biosafety cabinet.  
Isolates were maintained on potato dextrose agar [PDA; 20 g/L dehydrated mashed 
potatoes (Idaho Spuds, Pillsbury, Minneapolis, MN), 20 g/L glucose, 15 g/L agar (Bacto-
Agar, Difco, Detroit, MI)] at room temperature or at 37 ºC.  Cultures for analysis of ergot 
alkaloids were grown on PDA at 37 ºC.  For the preparation of DNA or protoplasts, the 
fungus was cultured overnight in 15 mL of potato dextrose broth (Difco) in a deep Petri 
dish (20-mm depth, 100-mm diameter; Fisher Scientific, Pittsburgh, PA) in an orbital 
shaker set at 37 ºC and 150 rpm.  Cultures were inoculated by lightly dusting the medium 
with conidia that had adhered to a Petri dish lid formerly covering a mature culture.  In 
mock inoculations, an average of 2.1 × 105 conidia per cm2 was deposited by this 
inoculation method.   
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Analysis of the A. fumigatus genome for ergot alkaloid biosynthesis genes.  
Aspergillus fumigatus preliminary sequence data were obtained from The Institute for 
Genomic Research website at http://www.tigr.org.  All A. fumigatus sequences described 
in this paper are located on assembly 92 (long arm of chromosome 2, formerly assembly 
72) between nucleotides 2,894,958 to 2,926,335.  The presence of sequences in the A. 
fumigatus genome that are similar to known or putative ergot alkaloid biosynthesis genes 
was assessed by application of the tblastn algorithm (1) at the National Center for 
Biotechnology Information (NCBI) website (www.ncbi.nlm.nih.gov) with the deduced 
protein sequences of DMAT synthase from Claviceps fusiformis (24) and LPS1 of N. lolii 
(16) or C. purpurea (26) as query sequences.  The nature of genes linked to the ergot 
alkaloid biosynthesis genes or candidate genes was investigated by retrieving contiguous 
2-kb segments of DNA from the A. fumigatus genome and querying the nonredundant 
protein database of NCBI with these sequences by application of the blastx search 
algorithm (1).   
Knockout of dmaW in A. fumigatus.  Fungal DNA for amplification by PCR 
was isolated following the Gene Clean Spin protocol (Bio 101, Vista, CA).  An internal 
fragment of A. fumigatus dmaW (encoding amino acids 136 to 352 of the predicted 497 
amino acid product) was amplified by PCR from primers dmaW forward (5'-
TTGATCTGGAGTGGTTCCGC-3') and dmaW reverse (5'-
CGTTCATGCCGAGGTTGTG-3').  A 50 µL PCR reaction contained 50 mM KCl, 10 
mM Tris-HCl (pH 9.0), 0.1% (v/v) Triton X-100, 1.5 mM MgCl2, 200 µM of each 
deoxyribonucleotide triphosphate, 1 µM of each primer, and 2.5 units of Taq DNA 
polymerase (Promega, Madison, WI), which was added once the thermocycler reached 95 
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ºC in the initial denaturing period.  The reaction began with an initial denaturing time of 2 
min 30 s at 95 ºC, followed by 35 cycles of 1 min at 94 ºC, 1 min at 55 ºC, and 1 min at 
72 ºC.  The 651-bp dmaW PCR product was ligated into pCR2.1 (Invitrogen, Carlsbad, 
CA) based on T/A overhangs and transformed into chemically competent Escherichia 
coli cells.  The resulting 4.5-kb gene knockout construct, pDMAT1, was linearized at a 
unique PpuMI site within the dmaW coding sequences prior to transformation of A. 
fumigatus.   
Protoplasts of A. fumigatus were prepared according to Murray et al. (11), except 
that 5 mg/mL of Driselase (InterSpex, Foster City, CA), 1.3 mg/ml Novozyme 234 
(InterSpex) and 25 µg/mL chitinase (Sigma, St. Louis, MO) were used as lysing 
enzymes.  Cotransformation of the protoplasts with PpuMI-linearized pDMAT1 and the 
hygromycin resistance-conferring plasmid pMOcosX (12)(linearized at a unique NotI 
site) was performed as previously described by Panaccione et al. (16), but with 4 µg of 
each DNA in 10 µL of water.  Considering the relative differences in the lengths of the 
respective cotransformed molecules, the equal masses introduced corresponded to an ~2-
fold molar excess of the gene knockout construct (pDMAT1, 4.5 kb) relative to the 
selectable marker (pMOcosX, 8.8 kb).  The transformation mixture was divided into 6 
aliquots and plated on regeneration medium containing 300 µg/mL hygromycin 
(Calbiochem, La Jolla, CA) as previously described (16).  Transformation plates were 
incubated at 37 ºC for two days and hygromycin-resistant colonies were transferred onto 
PDA plates containing 400 µg/mL hygromycin.   
Transformants were screened for homologous recombination of pDMAT1 with 
the native dmaW gene by PCR (same conditions as above, except annealing temperature 
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was 57 ºC) from primers UF (5'-TGTAAAACGACGGCCAGTGAAT-3'; which anneals 
to vector sequences near the universal primer annealing site pCR2.1) and 3S (5'-
AAGTAAGTCCCGAGCTGTTCAT-3'; which anneals to dmaW sequences near the 3'-
end of the gene and flanking the intended site of integration)(Fig. 1A).  Transformants 
yielding a fragment of the expected size for a gene knockout at dmaW (1.2 kb) were 
purified to nuclear homogeneity by culturing from individual, germinated conidia.  
Single-spored colonies were again screened by PCR (conditions as described 
immediately above but with annealing temperature of 60 ºC) but with primers UR (5'-
AGCTATGACCATGATTACGCCA-3'), which anneals to vector sequences near the 
reverse primer annealing site of pCR2.1, and primer 5S (5'-
TAGTGAGATACACATTCGAGCC-3'), which anneals to dmaW sequences near the 5'-
end of the gene and flanking the intended site of integration (Fig. 1A).  In this way, both 
the 5' and 3' borders of the integration site were analyzed by PCR.  Candidate gene 
knockout strains also were screened with primers 5S and 3S under PCR conditions 
described above and with an annealing temperature of 57 ºC.  Finally, transformants 
producing fragments of expected sizes in the PCR analyses were analyzed further by 
Southern hybridization as described below.   
Fungal DNA for Southern blot hybridization was digested with SalI, size-
fractionated by electrophoresis through 0.8% agarose, and transferred to Biodyne A 
nylon membrane (Pall-Gelman Sciences, Ann Arbor, MI) by capillary action with 20× 
SSC (1× SSC is 150 mM NaCl + 15 mM trisodium citrate) as the transfer medium.  A 
dmaW probe was labeled with DIG-dUTP by amplifying wild type genomic DNA by 
PCR from primers dmaW forward and dmaW reverse (described above).  PCR conditions 
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were as described above except with 1× DIG DNA Labeling Mix (Roche Applied 
Science, Indianapolis, IN) replacing standard dNTPs.  Hybridization was performed at 65 
ºC in 5× SSC, 0.1% (w/v) N-lauroylsarcosine, 0.2% (w/v) sodium dodecyl sulfate, 1% 
(w/v) blocking reagent (Roche), 10 mM maleic acid, and 15 mM NaCl (pH 7.5).  Final 
washes were with 0.5× SSC + 0.1% SDS at 65 ºC.  Bound probe was detected with anti-
DIG antibody followed by chemiluminescence by standard methodology (DIG Manual, 
Roche Applied Science, Indianapolis, IN). 
An ergot alkaloid-deficient dmaW knockout strain was complemented with a full-
length dmaW-containing fragment produced by PCR from primers 5'-
GAGAGTGGTGTTGAGAGCTGCC-3' and 5'-CCTTCAGGCTTCATGAACGGAC-3', 
which prime amplification of a 3.4-kb fragment containing the entire dmaW coding 
sequence along with 784 bp of 5'-flanking sequence and 1,123 bp of 3'-flanking 
sequence.  PCR conditions were as described above except the annealing temperature 
was 57 ºC and the extension time at 72 ºC was 3 min 20 s.  The PCR product was co-
transformed into a dmaW knockout strain along with phleomycin resistance-conferring 
plasmid pBC-phleo (22; Fungal Genetics Stock Center, University of Missouri-Kansas 
City, Kansas City, MO).  Selection was on complete regeneration medium (16) 
containing phleomycin at 100 µg/mL.   
Analysis of ergot alkaloids.  Ergot alkaloids were analyzed from conidia 
produced on PDA by extraction with 80% methanol and analyzed by HPLC with 
fluorescence detection as described previously (13).   
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RESULTS 
Identification and analysis of a dmaW homolog in A. fumigatus.  A search of the A. 
fumigatus genome database revealed an excellent match for C. fusiformis dmaW, which 
encodes the enzyme dimethylallyltryptophan synthase (DMAT synthase) that catalyzes 
the first step in the ergot alkaloid pathway in clavicipitaceous fungi.  The deduced A. 
fumigatus DMAT synthase was 50% identical to DMAT synthase from C. fusiformis 
(24), 53% identical to DMAT synthase from C. purpurea (26), and 59% identical to the 
DMAT synthase of Neotyphodium sp. Lp1 (29).  The A. fumigatus dmaW sequence 
contained a single intron at an identical position to the single intron in the dmaW genes 
isolated from the Claviceps and Neotyphodium spp. (data not shown).  
A gene knockout construct, designed to integrate at dmaW by a single crossover 
(Fig. 1) was targeted to the dmaW locus in 3 of 25 hygromycin-resistant transformants 
analyzed (Figs. 1 and 2).  PCR analysis of the 5' and 3' junctions of the native dmaW gene 
and the integrated gene knockout construct yielded fragments of the expected length for 
homologous recombination of such a construct at dmaW (Figs. 1B and 1C).  PCR 
amplification of the gene knockout strains from primers 5S and 3S, spanning the site of 
recombination, failed to yield the 1.2-kb product amplified from the wild-type isolate 
(data not shown).  Southern hybridization of DNA from the putative knockout strains 
digested with SalI, which has sites flanking the targeted integration site and not within 
the knockout construct, indicated that three or more copies of the knockout construct 
integrated in tandem at dmaW in these transformants (Fig. 2).   
The dmaW knockout strains did not produce any of the known ergot alkaloids 
(Fig. 3).  Additional peaks, including uncharacterized molecules eluting at 55.5 min and 
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56 min (Fig. 3) and a minor peak eluting at 32.8 min (evident only upon viewing the 
traces at much higher sensitivity), also were eliminated by knockout of dmaW.  The peak 
eluting at 32.8 minutes is proposed to contain one or more of the isomers of chanoclavine 
based on a measured mass of 256 and its co-elution with a chanoclavine standard.  The 
later-eluting molecules have not been characterized further.   
Transformation of strain dmaW ko6 with a DNA fragment containing the entire 
dmaW coding sequences plus 784 bp of 5'-flanking sequences and 1,123 bp of 3' flanking 
sequences restored the ability to produce ergot alkaloids (Fig. 3).  The complementing 
fragment was determined to have integrated ectopically, because the gene knockout 
construct was retained at the native dmaW locus (data not shown).  All known A. 
fumigatus ergot alkaloids were produced in the complemented strains (Fig. 3).    
Genes clustered with dmaW in A. fumigatus.  Database searches with five C. 
purpurea gene sequences, which in addition to dmaW have been proposed to be involved 
in ergot alkaloid biosynthesis (but which have not yet been functionally analyzed), 
identified potential homologs clustered with each other and with the dmaW homolog on 
A. fumigatus (Fig. 4).  These included two putative oxidoreductase-encoding genes 
identified as cpox1 and cpox2, as well as a catalase-encoding gene, and two unidentified 
open reading frames (labeled orfA Cp and orfB Cp) whose sequence and close linkage 
with dmaW are conserved in C. purpurea (25, 26) and C. fusiformis (10).  Despite the 
similarity in the composition of the clusters of genes associated with dmaW in A. 
fumigatus and C. purpurea, the physical arrangement in terms of the orientation and 
order of genes within the cluster differed in the two fungi (Fig. 4).   
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Analysis of additional sequences clustered on the dmaW contig of A. fumigatus 
identified several other genes that may encode enzymes in the ergot alkaloid pathway 
(Fig. 4).  These include sequences similar to cytochrome P450 monooxygenases, a FAD-
dependent monooxygenase, and short chain alcohol dehydrogenases.  Additional 
sequences whose deduced functions are consistent with roles in formation of the side 
chains that vary among the three fumigaclavines also were identified.  These include any 
of several monooxygenases or hydroxylases, an O-acetyl transferase, and a divergent 
dmaW-like (prenyl transferase) gene.  The predicted product of the divergent dmaW-like 
gene had 25% identity with the deduced product of A. fumigatus dmaW required for ergot 
alkaloid biosynthesis and had 26%, 25%, and 27% identity with the deduced products of 
dmaW from C. purpurea, C. fusiformis, and Neotyphodium sp. Lp1, respectively.   
DISCUSSION 
Our results demonstrate that the genome of the A. fumigatus contains a homolog of 
dmaW that is required for ergot alkaloid biosynthesis.  The loss of all known ergot 
alkaloids upon inactivation of dmaW in A. fumigatus indicates that this gene controls the 
determinant step in the ergot alkaloid pathway of A. fumigatus, as it does in the 
clavicipitaceous fungus Neotyphodium sp. Lp1 (29).  Moreover, in the A. fumigatus 
genome, dmaW is clustered with genes similar to, and extending, the ergot alkaloid gene 
cluster observed in the ergot fungus C. purpurea.  Collectively the data indicate a 
common biosynthetic and genetic origin for the ergot alkaloids of A. fumigatus with those 
of the ergot alkaloid-producing members of the Clavicipitaceae.   
Each of the three gene knockout strains investigated contained three or more 
copies of the knockout construct integrated at dmaW.  The multiple integrations may have 
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resulted from either or both of two modifications of the more typical gene knockout 
strategy that we applied in this experiment.  First, the knockout construct was introduced 
by cotransformation at two-times the molar concentration of the selectable marker 
construct.  Second, the knockout was created by integrating an internal fragment of the 
gene via a single crossover, a strategy that has resulted in multiple integrations in 
previous studies with other fungi (e.g., 2, 17, 18, 21).  This particular approach was 
chosen for two reasons.  Knockout construct can be easily prepared in a single cloning 
step, which should facilitate similar analyses on many of the genes in the cluster.  Also, 
since we intended to complement the mutation in a subsequent step, any phenotype 
associated with ectopic integration of the cotransformed selectable marker construct 
would have been revealed at that stage.  The observations that three independent 
transformants containing the integration at dmaW lacked ergot alkaloids and the 
complementation restored ergot alkaloid production indicate that the strategy provides a 
reasonable means for rapid analysis of gene function.   
 Aspergillus fumigatus produces at least four ergot alkaloids, all belonging to the 
clavine class of ergot alkaloids (4, 13, 23).  Close analysis of peaks eliminated in the gene 
knockout versus wild-type strains in this current study indicated that conidia of A. 
fumigatus also contain small quantities of chanoclavine.  This is not surprising since 
chanoclavine is an early pathway intermediate in the biosynthesis of all known ergot 
alkaloids and it accumulates to varying degrees in different ergot alkaloid producers (7, 8, 
14, 15, 25).   
Among the ergot alkaloids produced by A. fumigatus, only festuclavine and 
chanoclavine have been detected in any of the studied clavicipitaceous ergot alkaloid 
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producers (6, 7, 15, 19).  Conversely, the ergot alkaloid-producing members of the 
Clavicipitaceae produce numerous ergot alkaloids that are not found in A. fumigatus.  
These include the ergopeptines (tripeptide derivatives of lysergic acid) and simple amides 
of lysergic acid (such as ergonovine and ergine).  The production of both the ergopeptine 
and simple amide classes of ergot alkaloids is dependent upon the activities or products 
of lysergyl peptide synthetases (5, 15, 16).  Based on the ergot alkaloid profiles and 
sequences clustered with dmaW in A. fumigatus versus C. purpurea, we hypothesize that 
the early stages of the pathway are shared in the A. fumigatus and C. purpurea but that 
later steps in the pathways differ in the respective fungi.  
 The ergot alkaloid pathways of A. fumigatus and C. purpurea probably share 
several steps in addition to the determinant step catalyzed by DMAT synthase.  The 
cluster of genes immediately around dmaW in A. fumigatus contains five hypothetical 
genes that are highly similar to genes previously hypothesized to be involved in the early 
stages of the ergot alkaloid pathway of C. purpurea (5, 25, 26).  These include the 
following: a sequence labeled orfB, which encodes a product similar to a methyl 
transferase, an activity required for the second step in the pathway; two genes (cpox1 and 
cpox2) encoding oxidoreductase that may catalyze early steps in the pathway (7, 14, 25); 
a sequence labeled orfA, for which a biochemical function has not been proposed; and, a 
catalase-encoding gene.  A function for the catalase in ergot alkaloid biosynthesis is not 
obvious.  One possibility is that it may act peroxidatively to oxidize the primary alcohol 
of chanoclavine to the corresponding aldehyde, which is a step required prior to 
cyclization of the fourth ring of the basic four-membered ergoline ring system.  
Interestingly, the orientation and position of three members of this putative core set of 
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genes differ in the clusters of the two fungi, suggesting that numerous recombination 
events occurred after divergence of the lineages of these two fungi.  Alternatively, if the 
cluster had been acquired by horizontal gene transfer, then the dissimilarities indicate 
than any such transfer would have been ancient.  
We propose that after a shared early stage, the ergot alkaloid pathways of A. 
fumigatus and the clavicipitaceous fungi diverge to yield different end products.  Cultures 
of A. fumigatus do not contain detectable levels of the later products of the pathway such 
as lysergic acid or lysergyl derivatives such as ergopeptines (13).  Consistent with this 
hypothesis, searches with fragments of genes encoding LPS1 (an enzyme required for the 
assembly of the ergopeptine class of ergot alkaloids from lysergic acid and three amino 
acids) from N. lolii (16) or C. purpurea (26) produced only low-level matches to 
miscellaneous peptide synthetase genes in the A. fumigatus genome.  The degree of 
identity observed was typical of the identity among peptide synthetases catalyzing the 
assembly of unrelated nonribosomally synthesized peptides in fungi (27), and none of 
these low-level matches was located near the dmaW gene.   
Conversely, the A. fumigatus cluster contained genes not found in C. purpurea 
cluster.  Some of these hypothetical genes encode functions that we hypothesize to be 
involved in the later steps of the A. fumigatus pathway leading from festuclavine to the 
fumigaclavines, which are not produced by C. purpurea.  For example, product of the 
gene in the A. fumigatus cluster predicted to encode an O-acetyltransferase may function 
in acetylating fumigaclavine B to fumigaclavine A.  The unusual, alternate dmaW gene 
(labeled alt dmaW in Fig. 4) may control the prenylation of fumigaclavine A to 
fumigaclavine C.  The lack of ergot alkaloids in the mutant containing a knockout at the 
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typical dmaW demonstrates that the highly divergent dmaW-like prenyl transferase gene 
found in the cluster is not functionally redundant with dmaW and, thus, may catalyze 
another prenylation step.     
The available data for A. fumigatus extend further than the published ergot 
alkaloid cluster data from C. purpurea, revealing several additional genes potentially 
involved in ergot alkaloid production.  Systematic gene knockouts and their 
characterization should allow definition of the early (and probably shared) steps of the 
ergot alkaloid pathway, several of which have been difficult to characterize 
biochemically (7, 8, 14).  Ergot alkaloid-deficient mutants such as the dmaW knockout 
may be useful for assessing the contribution of ergot alkaloids to virulence towards 
animals or potential contributions of the alkaloids to the success of A. fumigatus.   
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FIGURE LEGENDS 
Figure 1: (A) Diagrammatic representation of homologous recombination at dmaW.  In 
the wt diagram, F and R represent annealing sites for primers dmaW forward and dmaW 
reverse, respectively, which amplify an internal portion of dmaW.  Gene knockout 
construct, pDMAT1, containing the internal fragment of dmaW, was linearized at a 
unique PpuMI site internal to dmaW prior to transformation.  The diagram labeled ko 
represents the dmaW locus with three copies of pDMAT1 integrated in tandem, 
disrupting dmaW.  UF = annealing site for primer derived from universal primer 
sequences in vector; 3S = annealing site for primer flanking the 3' border of the site of 
integration; UR= annealing site for primer derived from reverse primer sequences in 
vector; 5S = annealing site for primer flanking the 5' border of the site of integration.  (B) 
Primers UR and 5S amplified the expected 852-bp band from a strain carrying the 
disrupted dmaW allele but not from the wild-type isolate.  (C) Primers UF and 3S 
amplified the indicated 1.2-kb product only from the strain with disrupted dmaW.  
Relative mobility of relevant fragments (sizes in kb) of BstEII-digested bacteriophage 
lambda is indicated in each panel. 
 
Figure 2:  Southern blot of SalI-digested DNA from non-transformed A. fumigatus and 
three dmaW knockout mutants probed with a dmaW fragment derived from primers 
dmaW forward (F) and dmaW reverse (R).  Relative intensity of hybridization reflects 
minor differences in loading of samples.  Relative mobility of relevant fragments (sizes in 
kb) of BstEII-digested bacteriophage lambda is indicated.  
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Figure 3: HPLC traces of non-transformed A. fumigatus (wt), a dmaW knockout strain 
(dmaW ko6), and strain dmaW ko6 complemented by ectopic integration of a DNA 
fragment containing the gene (dmaW ct).  Insert (within wt panel) contains overlaid traces 
of non-transformed A. fumigatus (solid line; wt), strain dmaW ko6 (dotted line; ko), and 
the complemented strain (dashed line; ct), shown at higher sensitivity to demonstrate the 
presence or absence of fumigaclavine B.  B = fumigaclavine B; F = festuclavine; A = 
fumigaclavine A; C = fumigaclavine C.   
 
Figure 4: Map of the genes clustered with dmaW of A. fumigatus compared to the cluster 
surrounding dmaW of C. purpurea (redrawn from ref. {25}).  Arrows indicate the 
orientation of transcription.  Abbreviations: Cp, C. purpurea; ox/red, oxidoreductase; cat, 
catalase; OAc trans, O-acetyl transferase; P450, cytochrome P450 monooxygenase; lovA 
P450, similar to P450 involved in lovastatin biosynthesis; pda P450, similar to P450 
involved in pisatin demethylase activity; DH, short chain alcohol dehydrogenase; alt, 
alternate; OYE, old yellow enzyme; hydrox, hydroxylase; monoox, monooxygenase; ps, 
peptide synthetase.  To the right of orfB Cp in A. fumigatus (as drawn in Fig. 4) is a 
metalloproteinase-encoding gene and a retrotransposon-rich region, after which the 
assembly ends.  To the left of the illustrated A. fumigatus cluster are several genes 
encoding unknown hypothetical proteins, a few additional genes with deduced products 
also potentially involved with ergot alkaloid biosynthesis, as well as interspersed genes 
for which no role in ergot alkaloid biosynthesis can be deduced.  Genes that are found in 
the same relative position and orientation in the two clusters are indicated by inclusion in 
a solid-lined box.  Genes previously proposed to be involved in ergot alkaloid production 
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that are present in both clusters but differ in their relative position and orientation are 
enclosed in dashed-line boxes.  Genes for which a function has been demonstrated by 
gene knockout (5, 16, 29) are indicated with an asterisk.  The A. fumigatus sequences 
illustrated span from nucleotides 2,894,958 to 2,926,335 of assembly 92 (long arm of 
chromosome 2; formerly assembly 72) of the A. fumigatus genome.  Identifiers for the A. 
fumigatus sequences (as presented from left to right) are m19874, m19875, m19876, 
m19877, m19878, m19880, m19881, m19882, m19883, m19884, m19885, m19886, 
m19888, and m19891, respectively.  Data are available from The Institute for Genomic 
Research (www.tigr.org).  Accession number for C. purpurea orfA = AY836771, and for 
C. purpurea orfB = AY836772.  Accession numbers for the remainder of the genes found 
in the C. purpurea cluster are reported in refs. 5, 25, and 26. 
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CHAPTER 2: Clustered genes, easE and easF, common to 
Aspergillus fumigatus and ergot fungi control early steps in 
ergot alkaloid biosynthesis  
 
ABSTRACT 
Ergot alkaloids are mycotoxins typically associated with clavicipitaceous fungi and cause 
toxicoses to exposed individuals through their interactions with multiple neurotransmitter 
receptors.  Ergot alkaloids also are produced by the opportunistic human pathogen, 
Aspergillus fumigatus; however, its chemical profile consists of certain clavines as 
opposed to the lysergic acid derivatives typically observed in clavicipitaceous fungi.  
These fungi are hypothesized to share early steps in ergot alkaloid synthesis prior to 
divergence into two lineage-specific pathways.  Genes involved in ergot alkaloid 
synthesis are clustered, and several homologues are shared between the two groups of 
fungi.  This study focuses on two genes hypothesized to function early in ergot alkaloid 
biosynthesis, easE and easF.  Functional analysis via gene knockout demonstrated that 
both genes are required for ergot alkaloid biosynthesis in A. fumigatus.  When either of 
the genes was knocked out, transformants failed to produce chanoclavine or any ergot 
alkaloids downstream of chanoclavine, but different intermediates accumulated.  Strains 
with a mutated easF accumulated an alkaloid with properties of dimethylallyltryptophan 
(DMAT), a result consistent with easF encoding the N-methyl transferase that acts on 
DMAT.  Strains in which easE was mutated accumulated an intermediate with properties 
of N-methyl-DMAT.  These data indicate that easE encodes the first oxidase in the ergot 
alkaloid pathway.  Mutants of easF accumulated trace quantities of downstream 
intermediates, suggesting a route to circumvent this enzyme, presumably by the activity 
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of DMAT synthase on abrine (N-methyl-transferase) which is present in cultures of A. 
fumigatus.  This study further elucidates the early steps in the pathway in A. fumigatus, 
steps that are also shared with clavicipitaceous fungi.   
 
Keywords:  Aspergillus fumigatus, Claviceps spp., easE, easF, ergot alkaloid, 
methyltransferase, oxidoreductase 
INTRODUCTION 
Ergot alkaloids can be classified into three groups: clavines, ergopeptines, and simple 
amides (12, 14).  Clavines are the simplest of the ergot alkaloids, some of which serve as 
precursors of lysergic acid.  Ergopeptines and simple amides are derivatives of lysergic 
acid.  Clavicipitaceous fungi, such as Claviceps spp. and Neotyphodium spp., produce 
different end products compared to the distantly related saprophyte Aspergillus 
fumigatus.  All three types of alkaloids are found in clavicipitaceous species, but the 
spectrum of alkaloids can vary dependent on species and/or isolate (3, 6, 9).  Aspergillus 
fumigatus only produces clavines, such as festuclavine and fumigaclavines A, B, and C 
(1, 15, 19).  Panaccione (9) hypothesizes that the ergot alkaloid biosynthesis pathway 
diverges into two lineage-unique pathways after the production of chanoclavine 
aldehyde, resulting in different ergot alkaloid profiles between A. fumigatus and 
clavicipitaceous fungi.   
 Comparison of ergot alkaloid profiles and relevant DNA sequence data from 
different ergot alkaloid-producing fungi has led to the hypothesis that these fungi share 
early steps within the ergot alkaloid biosynthesis pathway (2, 9, 12).  
Dimethylallyltryptophan (DMAT) synthase is the determinant step in both A. fumigatus 
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and Neotyphodium sp. Lp1 (2, 16, 18).  In A. fumigatus, C. purpurea, C. fusiformis, and 
E. festucae, the gene encoding DMAT synthase is clustered among several genes whose 
products have predicted functions that may play a role in the ergot alkaloid pathway.  
Seven genes are common to the DMAT synthase-based clusters of each of these fungi 
and have been labeled as eas genes (14).  This study focuses on characterization of easE 
and easF, two genes found in the A. fumigatus and the clavicipitaceous ergot alkaloid 
gene clusters, via gene disruption in A. fumigatus and biochemical analyses of the gene 
disruption mutants. 
MATERIALS AND METHODS  
 Fungi and culture conditions.  Aspergillus fumigatus isolate FGSC A1141 (10) and 
mutant derivatives were maintained on potato dextrose agar [PDA; dehydrated potato 
flakes (Pillsbury, Minneapolis, MN) (20 g/L), D-glucose (20 g/L), and agar (15 g/L)].  
Protoplasts or DNA samples were prepared from cultures that were grown overnight in 
100 mL of malt extract medium (50 g malt extract, 50 g lactose, 5 g asparagine, and 0.4 g 
K2HPO4 per L) in a 250 mL Erlenmeyer flask on an orbital shaker set at 37 ºC and 150 
rpm.   
Disruption and complementation of easE and easF.  Internal (incomplete) 
regions of each putative gene’s coding sequence were amplified by PCR primed with the 
following oligonucleotides: easE-F (5'-CCAGATACATTGCCATCGCATG-3') and 
easE-R (5'-TGTTCCAACTGCTTGGCCAGAT-3') and easF-F (5'-
GCTTCAAAGATGGCAGCAGCTA-3') and easF-R (5'-
GAGTTGGCATAACTTAACGACG-3').  The 50 µL PCR reaction contained 50 mM 
KCl, 10 mM Tris-HCl (pH 9.0), 0.1% (v/v) Triton X-100, 1.5 mM MgCl2, 200 µM of 
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each deoxyribonucleotide triphosphate, 1 µM of each primer, and 2.5 units of Taq DNA 
polymerase (Promega, Madison, Wisconsin), which was added once the thermocycler 
reached 95 ºC in the initial denaturing period.  The reaction began with an initial 
denaturing step of 2 min and 30 sec at 95 ºC, followed by 35 cycles of 1 min at 94 ºC 
(denaturing), 1 min at 55 ºC (annealing), and 1 min at 72 ºC (extension), with a final 
extension step of 72 ºC for 7 min.  Amplification of the easE fragment was achieved with 
an annealing temperature of 57 ºC.  A disruption construct was generated to target each 
individual gene by ligating the PCR amplicon into the T/A overlap vector pCR2.1 
(Invitrogen, Carlsbad, California).  For easE and easF, a 4.8-kb construct (pEASE1) and 
a 4.5-kb construct (pEASF1) were produced, respectively (Fig. 1 & 2).  Prior to 
transformation into A. fumigatus, each disruption construct was linearized at a unique 
restriction site located within the gene specific region of the construct.  The restriction 
digests were as follows: pEASE1 with BspEI and pEASF1 with Bsu36I.   
Preparation and transformation of the protoplasts were previously described by 
Murray et al. (7) with modifications noted by Coyle and Panaccione [(2); Chapter 2], and 
instead of separation of protoplasts from debris by step-gradient centrifugation, 
protoplasts were filtered through cheesecloth.  In addition, the lysing enzymes were 
suspended in 0.7 M NaCl instead of osmotic medium to digest the fungal tissue.  The 
filtrate was centrifuged (5 min, 3436 x g) to pellet the protoplasts.  After filtration, the 
protoplasts were washed twice in 0.7 M NaCl and once in STC (1 M sorbitol, 50 mM 
Tris-HCl pH 7.4, 50 mM CaCl2 (7) to remove digestive enzymes prior to final suspension 
in STC.  Protoplasts were co-transformed with a linearized disruption construct 
corresponding to easE or easF and a hygromycin resistance plasmid, pMOcosX (8), 
58 
 
linearized at a unique NotI site.  A preliminary high performance liquid chromatography 
(HPLC) screen of colonies that arose on transformation plates identified transformants 
with altered ergot alkaloid profiles.  At least forty hygromycin-resistant colonies were 
isolated for each gene, and transformant colonies were screened in groups of ten until 
prospective mutants were identified.  These colonies were then grown from single spores 
to achieve nuclear homogeneity and then analyzed for verification of homologous 
recombination (described below).   
Homologous recombination between the disruption construct and its respective 
native gene was verified by three PCR assays similar to the PCR reaction described 
above, but with different primers and annealing temperatures.  For easE, the 5' border of 
the recombination event was confirmed by PCR (annealing temperature at 57 ºC) primed 
with oligonucleotides UF (5'-TGTAAAACGACGGCCAGTGAAT-3', which anneals to 
vector sequences near the universal primer annealing site in pCR2.1) and easE-Fscrn (5'-
ACTGAAGACGAGACATGTCATG -3', complementary to easE sequences near the 5'-
end of the gene and flanking the intended site of integration) (Fig. 1A).  The juxtaposition 
of sequences near the 3' border of the integration event was verified by PCR (annealing 
temp 57 ºC) primed from oligonucleotides UR (5'-AGCTATGACCATGATTACGCCA-
3', complementary to vector sequences near the reverse primer annealing site of pCR2.1), 
and easE-Rscrn (5'-TTCCTGTACGACACTCTGAAGT -3', which anneals to easE 
sequences near the 3'-end of the gene and flanking the intended site of integration) (Fig. 
1A).  PCR across the entire easE locus was conducted by priming with oligonucleotides 
easE-Fscrn and easE-Rscrn (both described above) at an annealing temperature of 57 ºC.  
For easF, the 5' border of the recombination event was confirmed by PCR (annealing 
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temperature at 48 ºC) primed with oligonucleotides UF (described above) and easF-Fscrn 
(5'-AAGTTGTCGAAGGTCTCACGAA -3', complementary to easF sequences near the 
5'-end of the gene and flanking the intended site of integration (Fig. 2A).  The 
juxtaposition of sequences near the 3' border of the integration event was verified by PCR 
(annealing temp 48 ºC) primed from oligonucleotides UR (described above) and easF-
Rscrn (5'-GTGATTAGAGATGCTTCGTGC -3', which anneals to easF sequences near 
the 3'-end of the gene and flanking the intended site of integration) (Fig. 2A).  PCR 
across the entire easF locus was conducted by priming with oligonucleotides easF-Fscrn 
and easF-Rscrn (both described above) at an annealing temperature of 45 ºC. 
Integration of the transformation construct also was analyzed by Southern 
hybridization as described previously (2), except for substitution of the respective gene 
specific probe.  Each gene-specific probe was made by amplifying wild-type A. fumigatus 
genomic DNA via PCR from primer pairs easE-F and easE-R or easF-F and easF-R, 
according to the PCR conditions described above, substituting 1× DIG DNA Labeling 
Mix (Roche, Mannheim, Germany) for unlabeled dNTPs.  Knockout and wild-type 
genomic DNA were digested with ApaI for easE, and HincII for easF for each 
corresponding Southern blot. 
Each null mutant strain was complemented with a fragment containing a full-
length copy of the respective coding sequences along with 1.3-kb and 1.4-kb of 5'-
flanking sequences and 0.8-kb and 1.2-kb of 3'-flanking sequences for easF and easE, 
respectively.  The complementing fragments were amplified by PCR using primer pairs 
described as follows:  easE, WeasE-F (5'-CTGCTCCAGCAGGTAGATCTTGATTC -3') 
and WeasE-R (5'-TAGAGGAGCACCCAGCTGAATGTCCT -3') and easF, WeasF-F 
60 
 
(5'-TCCATTCTTCGCTCGTTCAACCAGCAGG -3') and WeasF-R (5'-
CAGGACCTGTACCTAAAGCCTGGTAACC -3').  These fragments were each 
amplified in a 50 µL PCR reaction containing 15 mM (NH4)2SO4, 50 mM Tris-HCl (pH 
9.0), 0.1% (v/v) Triton X-100, 1.5 mM MgCl2, 200 µM of each dNTP, 1 µM of each 
primer, and 1 unit of DyNAzyme DNA polymerase (New England Biolabs, Beverly, 
MA) added during the initial denaturing step.  The thermocycler program was as 
described above.  However, the annealing temperatures and extension periods differed 
from above and from each other and they are as follows: easE, 55 ºC and 4 min 30 sec; 
and easF, 65 ºC and 3 min 20 sec.  Each PCR product was cotransformed into their 
respective gene’s-disrupted mutant along with a phleomycin resistance plasmid, pBC-
phleo (Fungal Genetics Stock Center, University of Missouri-Kansas City, Kansas City, 
MO).  Transformants were selected on complete regeneration medium (11) containing 
100 µg/mL phleomycin and incubated at 37 ºC.  Complemented transformants were 
cultured from individual spores to achieve nuclear homogeneity.  To test for the presence 
of the original disruption construct, PCR reactions were performed as described above 
(i.e. easE-F and UF).  An additional PCR screen was performed on each complemented 
transformant to test for the presence of the introduced wild-type allele.  These reactions 
were primed with primer pairs and reaction conditions stated above (i.e. WeasE-F and 
WeasE-R). 
Analysis of Ergot Alkaloids.  Cultures used for ergot alkaloid analysis were 
grown on PDA at 37 ºC for 1 wk.  Samples were prepared from whole plate extractions in 
4 mL 100% methanol, vortexed, and then rotated end-over-end for at least 2 hr.  Ergot 
alkaloids were detected and quantified from 20µL of the prepared sample by reverse-
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phase HPLC on a C18 column with fluorescence detection based on excitation and 
emission wavelengths of 272 nm and 372 nm, respectively (10).  The presence of ergot 
alkaloids that possess a 9,10 double bond was analyzed by passing eluates through a 
second fluorescence detector set with excitation and emission wavelengths of 310 nm and 
410 nm, respectively.  The peaks corresponding to festuclavine and fumigaclavines A, B, 
and C were previously identified by mass spectral analyses (10) and confirmed by 
elimination of these peaks in mutants that lack a functional dmaW, the first gene in the 
ergot alkaloid pathway (2).  The peak corresponding to chanoclavine was identified by 
coelution with authentic chanoclavine standard (provided by B.A. Tapper, AgResearch 
New Zealand).   
 Liquid surface cultures used for ergot alkaloid analysis were grown on malt 
extract medium at 37 ºC for 2 weeks, extracted in 4 mL 100% methanol over a period of 
2 hr with occasional vortexing.  Extracts were centrifuged to pellet spores and other 
fungal debris and supernatants were  concentrated in a speed vacuum and subjected to 
liquid chromatography – mass spectrometry (LC-MS) analysis (Chem. Dept., MIT).  The 
LC-MS samples were resolved on an Acquity Ultra Performance BEH C18 column with 
a 1.7 micrometer particle size, 2.1 x 100 mm dimension.  LC-MS was performed at a 
constant flow rate of 0.5 mL/min with a gradient described as follows: at 0 min: 20 parts 
acetonitrile and 80 parts 0.1% formic acid in water; at 5 min: 20 parts 0.1% formic acid 
in water and 80 parts acetonitrile; at 6 min: 80 parts 0.1% formic acid in water and 20 
parts acetonitrile.  Masses were detected by a Micromass LCT Premier TOF MS with an 
electrospray ionization source.     
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RESULTS 
Screening by HPLC indicated altered ergot alkaloid profiles in multiple hygromycin-
resistant colonies for both easE and easF transformants.  Incorporation of pEASE1 into 
the native easE gene in A. fumigatus via homologous recombination occurred in three of 
these transformants.  For easF, one hygromycin-resistant colony was identified to contain 
the pEASF1 within the native easF gene.   
DNA analyses via PCR and Southern blot confirmed insertion of the knockout 
(ko) constructs within their target gene.  All mutant colonies were started from single 
spores to achieve homokaryotic cultures.  For easE ko mutants, PCR screens across the 5’ 
and 3’ borders of the predicted integration site both produced the predicted 1.2-kb 
product, whereas the wild type lacked amplification from this primer pair (Fig. 1B).  A 
PCR screen designed to detect the intact wild-type locus was positive for the expected 
1.3-kb PCR product in the wild-type strain but did not detect a wild-type allele in the 
easE ko, because insertion of the ko construct within the native locus produced a large 
distance between priming sites (Fig. 1B).  PCR analysis of the integration site in an easF 
mutant produced 815-bp and 755-bp fragments from screens across the 5’ and 3’ borders 
of the integration site, as predicted (Fig.  2B).  The screen to detect the wild-type locus 
did not render a product from null mutant strains, again due to the insertion of the ko 
construct within the native easF gene.  The wild-type DNA did produce the 820-bp 
product.   
Southern blot analysis of easE mutants confirmed disruption of the native gene 
and showed multiple insertions of the pEASE1 within easE (Fig. 1C).  The Southern blot 
analysis for easF clearly showed insertion of the knockout construct in the easF mutant 
63 
 
due to a shift in the gene specific HincII fragment when compared to wild type (Fig. 2C).  
Multiple knockout constructs appeared to be inserted, which is not abnormal for this 
integration technique.  The presence of several bands suggests additional integrations or 
recombination among tandemly inserted knockout contstructs.  Complementation 
analyses (described below) show that the mutant phenotype was due to integration into 
easF. 
HPLC analyses showed that mutants of either easF or easE did not produce 
chanoclavine, festuclavine, or fumigaclavines A, B, or C (Fig. 3A & 4A).  The mutants of 
easF accumulated a compound with a retention time of 43 min that was not observed in 
wild type or in the easE mutants when analyzed by HPLC (Fig. 3A).  LC-MS analysis of 
this peak showed that the compound had a molecular ion with m/z of 273.16 (Fig. 3B).  
Since fragmentation with this ESI-source instrument is rare, the 273.16 m/z ion likely 
represents the molecular ion [M + H+] of a compound with molecular weight of 272.16.  
The more sensitive analysis on the LC-MS indicated the presence of small quantities of 
downstream intermediates, such as festuclavine.   
The easE ko accumulated a novel compound that eluted from the HPLC column 
at 44 min and by LC-MS yielded an ion with m/z of 287.17, indicative of the molecular 
ion of a compound of molecular weight 286.17 (Fig. 4).  This mutant did not contain any 
other downstream intermediates. 
Disrupted strains were complemented by cotransformation with a wild-type copy 
of their respective genes and NotI-linearized pBCphleo.  A 4.6-kb fragment containing a 
functional copy of easE complemented the easE ko.  Likewise, easF was complemented 
with a 2.9-kb PCR product containing a wild-type copy of the easF allele.  Positive 
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transformants were verified by PCR, when primed by either WeasE-f and WeasE-r or 
WeasF-f and WeasF-r (not shown).  Amplification of the 5’ and 3’ regions flanking the 
site of integration of the original knockout construct confirmed that both easE and easF 
complemented strains were derivatives of their original knockout mutants.  HPLC 
analyses demonstrated that colonies of the easE complemented and easF complemented 
strains accumulated festuclavine and fumigaclavines A, B, and C, similar to wild type 
(not shown). 
DISCUSSION 
These data demonstrate that easF and easE encode enzymes involved in the early steps of 
the ergot alkaloid pathway.  Knockout mutants of easE and easF lacked normal ergot 
alkaloid accumulation in A. fumigatus, decreasing or eliminating production of 
festuclavine and fumigaclavine A, B and C.  In addition, novel compounds with 
properties of intermediates in the ergot alkaloid pathway accumulated in these mutants, 
allowing proposed placement of the enzymes encoded by these genes at specific steps of 
the ergot alkaloid pathway.  
A. fumigatus easF is located 257 bp downstream of easE within the ergot alkaloid 
cluster on chromosome 2 and spans 1.1 kb of the genome [(2); Chapter 1].  Comparison 
of the linear sequence to a known protein database shows it has 56% and 60% identity to 
C. purpurea and N. lolii EasF, respectively.  EasF, both in A. fumigatus and C. purpurea, 
has been hypothesized to encode a methyltransferase (2, 4, 12), even though sequence 
data to support this were weak and closest sequence identity matches were to products of 
other unknown open reading frames.  Knockout of easF resulted in accumulation of a 
compound with a molecular weight of 272.16, which is the molecular weight of DMAT, 
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the first intermediate of the ergot alkaloid pathway.  During the later stages of this work, 
Rigbers and Li (2008) published results of expression assays done in vitro in Escherichia 
coli.  The expressed and isolated easF product methylated DMAT in the presence of S-
adenosylmethionine, illustrating easF encodes for a methyltransferase capable of using 
DMAT as a substrate.  My in vivo functional analysis of the easF gene supports the 
finding of the easF product functioning as a methyltransferase; the null mutant’s inability 
to methylate DMAT resulted in accumulation of DMAT.   
Interestingly, Unsold and Li (17) demonstrated that DMAT synthase of A. 
fumigatus, which typically uses tryptophan as a substrate, also can prenylate N-methyl-
tryptophan (abrine) resulting in N-methyl-DMAT.  This activity of DMAT synthase 
could theoretically bypass the requirement of the N-methyl transferase step.  LC-MS 
analyses of my easF mutants indicated a degree of leakiness in that trace quantities of 
festuclavine and fumigaclavines A and C were detectable in selected ion traces (data not 
shown).  Abrine was detectable in cultures of A. fumigatus, and thus may have served as 
an alternate substrate for DMAT synthase allowing a bypass of the mutated easF-
encoded step.   
The gene, easE, is found on the 2nd chromosome of A. fumigatus, between 
nucleotides 2925694-2927815; it is clustered with genes involved in ergot alkaloid 
production (2).  The Aspergillus sequence is 45% similar to the C. purpurea easE protein 
sequence, 43% similar to C. fusiformis oxidase, and 47% similar to a putative oxidase of 
N. lolii.  The easE sequence indicates that it encodes a FAD-containing oxidoreductase, a 
class of enzyme which would play a role in the proposed pathway (9, 12).  My results 
show that strains in which easE is inactivated accumulate an intermediate with 
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fluorescence properties typical of an ergot alkaloid with an 8,9 double bond and a 
molecular mass of 286.17, consistent with N-methyl-DMAT.  Chanoclavine and 
alkaloids downstream of chanoclavine are all eliminated by knockout of easE.  Based on 
these data, we hypothesize that the product of easE oxidizes N-methyl-DMAT.  More 
specifically, the easE product likely hydroxylates the benzylic carbon (position 10) of the 
isoprene group of N-methyl-DMAT, an oxidation step proposed by Kozikowski et al. (5).  
Synthetic intermediates in which that particular carbon is oxidized are unstable; the 10-
hydroxylated N-methyl-DMAT spontaneously dehydrates to the corresponding diene (Fig 
5), which has been demonstrated to be an authentic intermediate between N-methyl-
DMAT and chanoclavine (5).   
   These findings suggest that the initial steps in the ergot alkaloid pathway 
proceed as follows: the determinant step, DMAT synthase (encoded by dmaW) (2), is 
followed first by a methyltransferase (easF) and then by an oxidoreductase (easE).  This 
study uncovers the early steps of the pathway, allowing for a better understanding of its 
dynamics both in A. fumigatus and clavicipitaceous fungi.    
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FIGURE LEGENDS 
Figure 1: Disruption strategy for easE.  (A) EasE-F and easE-R primed amplification 
of internal region of easE.  Gene disruption construct pEASE1 contains this internal 
fragment and was linearized at a unique BspEI site prior to transformation.  The bottom 
panel illustrates insertion of three copies of the pEASE1 within genomic easE and the 
positions of primers used in PCR experiments to demonstrate integration at this locus.  
(B) Homologous recombination of the transforming DNA at easE was demonstrated by 
PCR with primers easE-Fscrn and UF confirming integration at the 5'-end of the gene and 
primers UR and easE-Rscrn confirming integration at the 3'-end.  Primer locations are 
shown in the bottom portion of part A.  The wild-type (wt) screen, used to assess the 
presence of the wild-type allele, was a PCR primed from easE-Fscrn and easE-Rscrn, and 
amplification does not occur from DNA that has disruption constructs within the intended 
site of integration due to the increase in template length.  PCR of non-transformed (wt) 
DNA gives a product of 1.3-kb.  (C) Incorporation of transforming DNA at the targeted 
site was confirmed by Southern blot hybridization.  Fungal DNA extracts were digested 
with ApaI and hybridized with a digoxigenin-dUTP labeled easE probe.  The large size of 
the easE-containing fragments in strains easE ko1, easE ko15, and easE ko31 indicate 
three or more copies of pEASE1 are present in the integration site.  The relative 
mobilities of relevant fragments of BstEII-digested bacteriophage lambda DNA are 
indicated on the left in panels B and C.   
 
Figure 2: Disruption strategy for easF.  (A) EasF-F and easF-R primed amplification 
of internal region of easF.  Gene disruption construct pEASF1 contains this internal 
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fragment and was linearized at a unique Bsu36I site prior to transformation.  The bottom 
panel illustrates insertion of three copies of the pEASF1 within genomic easF and the 
positions of primers used in PCR experiments to demonstrate integration at this locus.  
(B) Homologous recombination of the transforming DNA at easF was demonstrated by 
PCR with primers easF-Fscrn and UF confirming integration at the 5'-end of the gene and 
primers UR and easF-Rscrn confirming integration at the 3'-end.  Primer locations are 
shown in the bottom portion of part A.  The wild-type (wt) screen, used to assess the 
presence of the wild-type allele, was a PCR primed from easF-Fscrn and easF-Rscrn, and 
amplification does not occur from DNA that has disruption constructs within the intended 
site of integration due to the increase in template length.  PCR of non-transformed (wt) 
DNA gives a product of 820-bp.  (C) Incorporation of transforming DNA at the targeted 
site was confirmed by Southern blot hybridization.  Fungal DNA extracts were digested 
with HincII and hybridized with a digoxigenin-dUTP labeled easF probe.  The large sizes 
of the easF-containing fragments in strain easF ko1 indicate three or more copies of 
pEASF1 are present in the integration site.  Multiple bands suggest these strains are 
heterokaryons with varying number of pEASF1s inserted within target gene, due to 
deletion of one or more copies within some nuclei.  The relative mobilities of relevant 
fragments of BstEII-digested bacteriophage lambda DNA are indicated on the left in 
panels B and C.   
 
Figure 3: Chemical characterization of easF ko.  (A) HPLC chromatogram of wild-
type A. fumigatus (wt) and easF ko.  B = fumigaclavine B; F = festuclavine; A = 
fumigaclavine A; C = fumigaclavine C; CH = chanoclavine.  Numbers next to peak are 
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corresponding molecular weights. Excitation and emission wavelengths were 272 nm and 
372 nm, respectively. (B)  The ESI-MS mass spectrum of easF ko contains a 273.16 m/z 
ion, which corresponds to [M+H+] for DMAT. 
 
Figure 4: Chemical characterization of easE ko.  (A)  HPLC trace illustrating the 
chemical profiles of wild type (wt) and easE ko.  B = fumigaclavine B; F = festuclavine; 
A = fumigaclavine A; C = fumigaclavine C; CH = chanoclavine.  Numbers next to peak 
are corresponding molecular weights.  Excitation and emission wavelengths were 272 nm 
and 372 nm, respectively.  (B)  The ESI-MS mass spectrum of easE ko contains a 287.17 
m/z ion, which is characteristic of  [M+H+] for  N-methyl DMAT. 
 
Figure 5: Early steps in ergot alkaloid biosynthesis.  The gene, dmaW, has been shown 
to be the determinant step within the pathway and synthesizes DMAT (2).  The data 
suggest the easF product N-methylates DMAT, consistent with recent in vitro expression 
analyses (13).  The oxidoreductase encoded by easE acts on N-methyl-DMAT, 
presumably resulting in the formation of the diene intermediate previously identified in 
precursor feeding studies (5).  DMAPP = dimethylallylpyrophosphate; PPO = 
pyrophosphate; Trp = tryptophan; AdoMet = S-adenosylmethionine; DMAT = 
dimethylallyltryptophan.
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CHAPTER 3: An old yellow enzyme gene is required for ergot 
alkaloid biosynthesis and controls the branch point between 
Aspergillus fumigatus and Claviceps purpurea ergot alkaloid 
pathways   
 
ABSTRACT 
Ergot fungi in the genus Claviceps and several related grass endophytes in the genus 
Neotyphodium produce toxic ergot alkaloids.  Often these fungi produce a variety of ergot 
alkaloids including clavines as well as lysergic acid derivatives.   Ergot alkaloids also are 
produced by the distantly related, opportunistic human pathogen, Aspergillus fumigatus.  
However, this fungus produces festuclavine and fumigaclavines A, B, and C, which 
collectively differ from clavines of clavicipitaceous fungi in saturation of the last 
assembled of four rings in the tetracyclic ergoline structure.    The two lineages are 
hypothesized to share early steps of the ergot alkaloid pathway with divergence occurring 
at some point after the synthesis of the tricyclic intermediate chanoclavine.  Disruption of 
easA, a gene predicted to encode a flavin-dependent oxidoreductase of the old yellow 
enzyme class, in A. fumigatus led to accumulation of chanoclavine and an intermediate 
believed to be chanoclavine aldehyde.  Complementation of the A. fumigatus easA mutant 
with a wild-type allele from the same fungus restored the wild-type profile of ergot 
alkaloids.  Complementation of the A. fumigatus easA knockout with a homologue of 
easA from C. purpurea resulted in accumulation of alkaloids (agroclavine, setoclavine, 
and its isomer isosetoclavine) typical of clavicipitaceous fungi.  These data indicate that 
the old yellow enzyme encoded by easA is required for ergot alkaloid biosynthesis and 
functional differences in this enzyme in A. fumigatus and C. purpurea result in 
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divergence of their respective ergot alkaloid pathways.  Sequence analysis of easA 
homologues from several fungi producing different classes of ergot alkaloids indicates a 
difference in a residue previously shown to be critical for double bond reduction in other 
old yellow enzymes.  
 
Keywords:  Ergot alkaloid, Aspergillus fumigatus, easA, Claviceps spp., old yellow 
enzyme (OYE) 
INTRODUCTION 
Different classes of ergot alkaloids are produced by members of two distinct fungal 
lineages.  Clavicipitaceous species, which includes Claviceps spp. and Neotyphodium 
spp. (and its closely sexual relative, Epichloë spp.), are in the order Hypocreales and are 
known to synthesize lysergic acid derivatives, which include simple amides of lysergic 
acid and the more complex ergopeptines.  These alkaloids have an 8,9 or 9,10 double 
bond within the fourth ring of the tetracyclic ergoline structure.  Ergot alkaloid 
production also is associated with the distantly related opportunistic human pathogen, 
Aspergillus fumigatus, in the order Eurotiales (4, 7).  Aspergillus fumigatus ergot alkaloid 
biosynthesis renders simple clavines and differs significantly from the more complex 
profile of C. purpurea and Neotyphodium spp., with one important distinction being the 
saturation of the fourth ring of the ergoline structure (Fig. 1).     
 Several genes involved in the ergot alkaloid pathways of A. fumigatus and 
clavicipitaceous fungi are found clustered together within the genome of each species (2, 
3, 5, 19).  These distantly related fungi are hypothesized to share several early pathway 
steps, after which the pathways diverge to yield distinct sets of ergot alkaloids (12, 15).  
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The gene, dmaW, which encodes for a dimethylallyltryptophan (DMAT) synthase in 
Neotyphodium, functions similarly in A. fumigatus (2, 18, 20, 21).  Annotation of the 
regions surrounding this gene in A. fumigatus has identified potential homologues of 
genes also found in N. coenophialum and C. purpurea ergot alkaloid gene clusters (2).  
One of the shared genes, easA, is predicted to encode an old yellow enzyme (OYE).  Old 
yellow enzymes are flavin-containing oxidoreductases initially found in brewers’ bottom 
yeast (22).  Enzymes in this family use a reduced flavin cofactor and an active site 
tyrosine residue to reduce an α/β-unsaturated aldehyde or ketone.  Subsequently, the 
enzymes use NADPH to restore the flavin cofactor to its reduced state.  OYEs catalyze 
multiple reactions useful for both biotechnological and pharmaceutical applications; 
however physiological roles and natural substrates for many of these enzymes presently 
are unknown.  Based on the apparent need in the ergot alkaloid pathway of A. fumigatus 
for reduction of a carbon-carbon double bond in the intermediate chanoclavine aldehyde, 
we hypothesized that the OYE-encoding gene easA is required for ergot alkaloid 
biosynthesis (2, 15).  In this study, knockout and complementation analyses of easA in A. 
fumigatus are performed to ascertain the role of this gene product in ergot alkaloid 
biosynthesis.      
MATERIALS AND METHODS 
Fungi and culture conditions.  Aspergillus fumigatus isolate FGSC A1141 (13) and its 
mutant derivatives were cultured on potato dextrose agar (PDA; 20 g dehydrated potato, 
20 g glucose, and 15 g agar per liter).  Liquid cultures used for preparation of protoplasts 
or DNA were grown at 37 ºC on an orbital shaker (150 rpm) overnight in a 250 mL 
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Erlenmeyer flask containing 100 mL of malt extract medium (50 g malt extract, 50 g 
lactose, 5 g asparagine, and 0.4 g K2HPO4 per L).   
 Disruption and complementation of easA.    A 595-bp fragment within the 
coding sequence of easA was amplified by PCR, primed with oligonucleotides oyeF (5'-
ACCGAAGCAACAGACATCACC-3') and oyeR (5'-ATATGCGACATCCAATCGCC-
3').  The 50 µL PCR reaction contained 50 mM KCl, 10 mM Tris-HCl (pH 9.0), 0.1% 
(v/v) Triton X-100, 1.5 mM MgCl2, 200 µM of each deoxyribonucleotide triphosphate, 1 
µM of each primer, and 2.5 units of Taq DNA polymerase (Promega, Madison, 
Wisconsin), which was added once the thermocycler reached 95 ºC in the initial 
denaturing period.  The reaction began with an initial denaturing step of 2 min 30 sec at 
95 ºC, followed by 35 cycles of 1 min at 94 ºC, 1 min at 55 ºC, and 1 min at 72 ºC, with a 
final extension step of 72 ºC for 7 min.  A 4.5-kb disruption construct, pAFOYE1, was 
generated by ligating the PCR product into the T/A overlap vector pCR2.1 (Invitrogen, 
Carlsbad, California).  Prior to transformation into the fungus, pAFOYE1 was linearized 
by a restriction digest at the unique SmaI site within the easA region of the construct.  
Protoplast preparation and transformation were preformed as described by Murray et al. 
(10),with modifications previously noted by Coyle and Panaccione (2).  Protoplasts were 
separated from undigested hyphae by means of filtration through cheesecloth instead of 
step-gradient centrifugation.  Protoplasts in the filtrate were then pelleted by 
centrifugation (5 min, 3436 x g) and washed twice with 0.7M NaCl and once in STC (10) 
prior to a final resuspension in STC.  Linearized disruption construct pAFOYE1 (Fig. 
2A) and a hygromycin resistance plasmid, pMOcosX (11), linearized at a unique NotI site 
(2) were co-transformed into the protoplasts.  Transformants colonies were purified to a 
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homokaryotic state by culturing from single spores.  These cultures then were screened in 
three different PCR assays to identify strains in which the disruption construct inserted 
within the native easA.  With the exception of different primers and annealing 
temperatures, the PCR reactions are as described above.  The 5' border of the 
homologous recombination event was confirmed by PCR (annealing temperature at  
57 ºC) primed with oligonucleotides UR (5'- AGCTATGACCATGATTACGCCA -3', 
which anneals to vector sequences near the universal primer annealing site in pCR2.1) 
and oyeFscrn (5'-GGAAGATGTCATCTCCAACATAG-3', which is complementary to 
easA sequences near the 5'-end of the easA gene and flanking the intended site of 
integration) (Fig. 2A).  The juxtaposition of sequences near the 3' border of the 
integration event was verified by PCR (annealing temp 57 ºC) primed from 
oligonucleotides UF (5'- GCCAGTGAATTGTAATACGACTC -3', complementary to 
vector sequences near the reverse primer annealing site of pCR2.1), and oyeRscrn (5'-
AGCCTTCTCTTGATAGCGTGCT-3', which anneals to easA sequences near the 3'-end 
of the gene and flanking the intended site of integration) (Fig. 2A).  PCR across the entire 
easA locus was conducted by priming with oligonucleotides oyeFscrn and oyeRscrn 
(both described above) at an annealing temperature of 57 ºC.   
Integration of pAFOYE1 into the native easA also was analyzed by Southern 
hybridization as described previously (2).  Exceptions were inclusion of an easA-specific 
probe generated by amplifying wild-type A. fumigatus genomic DNA in a reaction 
primed with oyeF and oyeR according to the PCR conditions described above, and 
substitution of 1× DIG DNA Labeling Mix (Roche, Mannheim, Germany) for unlabeled 
dNTPs.  Genomic DNA was digested by SalI prior to Southern blot analysis. 
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The easA knockout (ko) strain was complemented by ectopic insertion of a 
functional copy of A. fumigatus easA into the mutant genome (easA ct).  This 3.3-kb 
fragment contained the entire coding sequence along with approximately 1.2-kb of 5'-
flanking sequences and 1.0-kb of 3'-flanking sequences and was amplified by PCR 
primed from WeasAF (5'-AGAATCGAGGTGAGCGTGTAGAATGC-3') and WeasAR 
(5'-AAGCTGGAACACTACTGATCGAGTGC-3').  Reaction conditions were similar to 
those previously described by Coyle et al. (1) except for an annealing temperature of  
58 ºC and an extension period of 3 min 30 sec.   
Additionally, the easA ko strain was complemented with the easA homologue 
from Claviceps purpurea strain ATCC20102.  Amplification of this gene was primed 
from CpoyeF (5’-TGAGTTCGAACGATGATCTGTAGCG -3’) and CpoyeR (5’-
TGAGTTCGAAAGAGTCTTCTACGCC -3’), with PCR conditions as described above, 
except for an annealing temperature of 54 ºC and an extension time of 2 min 30 sec.  The 
PCR product was co-transformed into an easA-disrupted mutant of A. fumigatus along 
with a phleomycin resistance plasmid, pBC-phleo (Fungal Genetics Stock Center, 
University of Missouri-Kansas City, Kansas City, MO) linearized at a unique NotI site.  
Transformants were selected on complete regeneration medium (14) containing 100 
µg/mL phleomycin and incubated at 37 ºC.  Complemented transformants were cultured 
from individual germinated conidia in order to achieve a homonucleate culture.  To test 
for the presence of the original disruption construct, PCR reactions were conducted as 
described above, primed with oyeFscrn and UR (for the 5' flank of the integration) and 
UF and oyeRscrn (for the 3' flank).  An additional PCR screen was performed with either 
primers WeasAF and WeasAR (described above) or CPoyeF and CpoyeR (described 
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above), to test for the presence of the introduced wild-type or C. purpurea allele in the 
complemented transformants (Cp easA ct).   
 Sequencing of easA from Claviceps spp.  Amplification of the C. purpurea 
strain ATCC20102 homologue of easA is described above, except using A. fumigatus 
easA complemented strain as template DNA.    Internal portions (corresponding to coding 
sequences for amino acids 19-341 based on the C. purpurea P1 (accession number 
CAG28312 sequence) of the Claviceps gigantea and Claviceps africana easA 
homologues were amplified in reactions primed with degenerative oligonucleotides 
ClavoyeF (5’- CACAAARTYGTRCTYTCTCCYATG -3’) and ClavoyeR (5’-
YGTGTCTCGRTTGTACTTYTGCAG -3’).  The reactions were described above, except 
for an annealing temperature of 48 ºC and extension period of 2 min.  PCR products were 
ligated into the pCR2.1 vector.  Sequencing was performed by Davis Sequencing 
(www.davissequencing.com, Davis, CA).  The initial round of sequencing for all three 
Claviceps spp. was primed from universal primers M13F and M13R.  To complete 
double-stranded sequence from the longer C. purpurea easA clone, a second round of 
sequencing was primed with custom primers CpoyeM13F2(5’- 
GATCAAGCAGCGAAGTACCG -3’) and CpoyeM13R2 (5’- 
TTGGAGGACTGGTCATGAGG -3’).   
 Sequences were aligned with additional available EasA sequences from ergot 
alkaloid producing fungi (C. purpurea strain P1 (accession number CAG28312), 
Neotyphodium lolii (accession number ABM91449), Claviceps fusiformis (accession 
number ABV57819), and Epichloë festucae, contig 3372 nucleotides 256-1251 (reverse, 
complement) within the available E. festucae genome  
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(http://www.genome.ou.edu/blast/ef_blastall.html), determined by tblastn with N. lolii 
EasA sequence corresponding to amino acids 19-350, by application ClustalW at the 
European Biotechnology Institute (EBI) web site (www.ebi.ac.uk/ClustalW/).  The 
alignment was analyzed in a distance analysis at the same EBI site (accepting defaults of 
all parameters) to construct a Neighbor-Joining tree.   
 Analysis of ergot alkaloids.  To analyze ergot alkaloid production, small cubes 
(containing approximately 8 mm x 8 mm of colony surface area) were removed from 
sporulating colonies that had been grown on PDA at 37 ºC for 5 days.  Samples were 
submerged in 0.4 mL of 80% methanol, vortexed briefly, rotated end-over-end (44 rpm) 
for 2 hr, and centrifuged (10 min., 14,000 x g) to pellet fungal mass and agar.  
Supernatants were analyzed by HPLC (C18 column) with acetonitrile-ammonium acetate 
gradients and detected with dual fluorescence detectors set at excitation and emission 
wavelengths of 272 nm / 372 nm and 310 nm / 410 nm (1, 13).  The identities of peaks 
corresponding to chanoclavine, festuclavine, and fumigaclavines A, B, and C were 
previously established by mass spectral analyses of native and de-esterified fractions 
(13).  These peak identities also were confirmed by their elimination in extracts from 
dmaW, a strain in which the determinant step of the ergot alkaloid pathway was 
inactivated (2).  Chanoclavine, agroclavine, setoclavine, and isosetoclavine were 
identified by coelution with standards, and their masses were confirmed by LC-MS (see 
below).    
  To quantify ergot alkaloids and conidiation from the wild type, easA ko and Cp 
easA ct samples, cultures were grown on PDA for 5 days at 37 ºC.  Samples,  
86 
 
containing 50.3 mm2 of colony surface area, were excised from cultures with the broader 
end of a disposable 1-mL pipette tip (Fisher Scientific, catalog number 02-681-172), 
submerged in 1 mL 80% methanol, agitated by vortexing, and rotated at 44 rpm for 2 hr.  
Aliquots were removed for HPLC analyses and for quantification of conidia.  
Concentrations of agroclavine, setoclavine, and isosetoclavine were based on peak area 
relative to the external standards of agroclavine (Sigma, St. Louis, MO) (for agroclavine) 
and ergotamine (for setoclavine and isosetoclavine) as previously described (Panaccione 
and Coyle 2005).  To determine spore counts, dilutions of the methanol extracts were 
prepared and conidia were enumerated with a hemacytometer and light microscope.  Five 
samples were analyzed for each treatment.  Data from easA ko and C. purpurea easA 
complemented strains were compared by Wilcoxon/Krustal-Wallis tests (rank sums). 
 Extracts for LC-MS analyses were prepared from cultures inoculated on the 
surface of liquid potato dextrose medium (PDA without agar, 50 mL in a 250-mL 
Erlenmeyer flask) and grown at 37 ºC with no agitation.  Ergot alkaloids were extracted 
by agitation in 4 mL of 100% methanol.  The methanol and dislodged conidia and hyphal 
fragments were transferred to microcentrifuge tubes, vortexed, and rotated end-over-end 
for a 2-hr period.  Then the sample was centrifuged (10 min., 14,000 x g) to pellet fungal 
material.  Methanol extracts and individual peaks collected from HPLC analysis 
performed as described above were concentrated under vacuum and sent to 
Massachusetts Institute of Technology for liquid chromatography-mass spectrometry 
(LC-MS) analyses.  LC-MS samples were separated on an Acquity Ultra Performance 
BEH C18 column with a 1.7 micrometer particle size, and 2.1 x 100 mm dimensions and 
were eluted with a linear gradient (0.5 mL/min) of 20 parts acetonitrile + 80 parts 0.1% 
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formic acid in water, initially, to 80 parts acetonitrile + 20 parts 0.1% formic acid in 
water at 5 min.  Masses of eluates were detected by a Micromass LCT Premier TOF MS 
with an electrospray ionization source.   
RESULTS 
Disruption and complementation of easA.  Integration of the disruption construct 
pAFOYE1 into the native easA gene of A. fumigatus via homologous recombination 
occurred in two out of the 64 hygromycin-resistant transformants.  Insertion of 
pAFOYE1 within easA was verified by PCR, with screens of the 5’ and 3’ borders of the 
integration resulting in 811-bp and 992-bp fragments, respectively (Fig 2B).  In the 
mutant, no 1-kb amplification product was detected when PCR was primed with 
oligonucleotides with binding sites separated from each other by 1-kb in the wild type 
due to the insertion of the disruption construct within the easA locus (Fig 2B).  Southern 
blot analysis showed multiple insertions of pAFOYE1 within easA by the shift in 
mobility of the easA-specific region (Fig 2C).   
 The easA mutants did not produce festuclavine or fumigaclavines A, B, and C, 
which are four ergot alkaloids typically detectable in A. fumigatus (13).  However, an 
important intermediate within the ergot alkaloid pathway, chanoclavine, which eluted 
from the HPLC column at 32.8 min, was observed in the mutant’s chemical profile (Fig 3 
& 4).  In addition, a 255.05 m/z fragment was observed by mass spectrometry within the 
easA ko extract, although elution time by HPLC was unknown (not shown).  Trace 
quantities of agroclavine, setoclavine, and isosetoclavine were identified in mutant 
extracts by coelution with standards (Fig. 3).  Co-transformation of a copy of A. 
fumigatus easA restored normal ergot alkaloid production.  This wild-type allele inserted 
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ectopically within the genome.  The construct, pAFOYE1, was verified to be inserted 
within the native easA locus by PCR screens of the recipient strain (Fig. 2B).   
 Complementation of easA mutant with easA homologue from C. purpurea.  
Ectopic insertion of the easA homologue from C. purpurea resulted in accumulation of 
larger quantities of agroclavine, setoclavine and its isomer isosetoclavine within the 
complemented strain (Table 1, Fig. 3).  The complemented strain was positive for the 
presence of the knockout construct, pAFOYE1 (not shown).  
 Analyses of easA sequences among ergot alkaloid producers.  The translated 
sequence of A. fumigatus easA was 57% similar to EasA homologues of N. lolii, C. 
fusiformis, and C. purpurea.  A. fumigatus easA consists of 1.1 kb of coding sequence 
uninterrupted by introns and has a tyrosine residue at the active site of the enzyme, as 
defined by analyses of Kluyveromyces marxianus old yellow enzyme.  The easA 
homologues of C. gigantea and C. africana (fungi that, like A. fumigatus, produce 
festuclavine and derivatives of festuclavine with a saturated “D” ring) also contain 
tyrosine at the active site (Fig. 5).  The easA homologues of N. lolii, E. festucae, C. 
fusiformis, and two isolates of C. purpurea (all of which produce clavines with 
unsaturated D rings) all have a phenylalanine substituted for the active site tyrosine (Fig 
5).  Based on overall amino acid sequence identity, the easA gene of A. fumigatus is most 
distant from the easA genes of the other festuclavine-producing fungi (C. africana and C. 
gigantea) (Fig. 6).   
DISCUSSION 
Disruption and complementation analyses of easA conducted in this study demonstrate 
that this gene is required for ergot alkaloid biosynthesis in A. fumigatus.  Disruption of 
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easA in A. fumigatus halted the conversion of chanoclavine into festuclavine.  Besides 
chanoclavine, this mutant also accumulated an intermediate with a molecular weight of 
254.05.  This intermediate is hypothesized to be chanoclavine aldehyde, an oxidized form 
of chanoclavine likely to serve as the substrate for the easA product.  However, the 
product was not present in sufficient concentration to perform further structural analyses.  
Chanoclavine aldehyde was hypothesized to be a transitional step between chanoclavine 
and festuclavine in the A. fumigatus ergot alkaloid biosynthetic pathway, which also was 
suggested by our knockout analysis and appears to be the last common intermediate 
between the A. fumigatus and ergot pathways prior to their divergence (Fig 7).   
The chemical profile of the easA knockout showed the presence of small 
quantities of agroclavine and its isomeric oxidation products setoclavine and 
isosetoclavine.  In total, these alkaloids were present at a concentration less than 0.03 
fg/conidium (Table 1).  We hypothesize that chanoclavine aldehyde, which accumulates 
due to the knock out of easA, tautomerizes to its enol form, thus allowing rotation of the 
aldehyde group attached at carbon 8 into close proximity to the N at position 6 for ring 
closure via a Schiff’s base reaction.  Since the 8,9 double bond was not reduced (due to 
the lack of EasA activity), agroclavine as opposed to festuclavine is the product.  
Agroclavine produced in this way may then be acted on by endogenous peroxidases to 
yield setoclavine and isosetoclavine.  The oxidation of agroclavine to yield setoclavine 
and its isomers by peroxidases from a variety of sources has been demonstrated 
numerous times (16).  Pseudomonas aeruginosa and peroxidases from homogenates of 
plants, such as tomatoes, potato sprouts, and morning glory seedlings, have been shown 
to conduct this bioconversion (8).  Complementation of the A. fumigatus easA knockout 
90 
 
with C. purpurea easA resulted in a significant increase in agroclavine, setoclavine, and 
isosetoclavine (Table 1).    
 While the A. fumigatus easA homologue may closely resemble the gene sequence 
of Claviceps purpurea easA, they differ in their enzymatic capabilities.  Both easA 
homologues resembles OYE, the flavin-dependent oxidoreductase (2).  Data from this 
study suggest that the pathways diverge after chanoclavine aldehyde, due to the differing 
enzymatic properties of EasA.  Chanoclavine aldehyde is an example of an α,β-
unsaturated aldehyde, a suitable substrate for OYE, which would have the capability to 
reduce the 8,9 double bond in chanoclavine aldehyde, allowing rotation of the aldehyde 
group to form dihydrochanoclavine aldehyde, and positions the aldehyde group close to 
the N-methyl group (22).  Formation of the C-N bond and closure of the fourth ring 
causes loss of H20, converting dihydrochanoclavine aldehyde into festuclavine, which is 
observed in A. fumigatus (15) (Fig 7).  Through complementation studies, our data 
suggest that C. purpurea EasA only temporarily reduces the 8,9 double bond in 
chanoclavine aldehyde so that agroclavine is synthesized instead of festuclavine.  
Agroclavine can be synthesized into setoclavine and its isomer by numerous peroxidases 
(16).  Chemical analyses indicate that peroxidases endogenous to A. fumigatus are 
capable of this conversion due to the accumulation of these two products (Fig. 3 & 4) 
 OYEs have been studied intensively in yeasts, and much is known about their 
mechanism and important active site residues (6, 9, 22).  OYEs reduce their substrates by 
a two-step mechanism.  Initially a hydride ion is transferred from the reduced flavin 
cofactor to the β carbon (relative to the aldehyde or ketone).  Subsequently, a proton is 
donated by Y196 which sits at the active site of the enzyme (9).  Yeast mutants with F 
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substituted for Y at that position transfer the hydride ion but never the second proton (6, 
9, 22).  Interestingly, C. purpurea EasA does not contain tyrosine at this position within 
its sequence and the phenylalanine substitution may be responsible for the differing 
enzymatic activity between the homologues.  The phenylalanine is incapable of donating 
the necessary hydrogen to the substrate.  Therefore, the enzyme cannot complete the 
reduction reaction even though the hydride ion was already transferred to the substrate, 
allowing temporary rotation of the 8,9 double bond in chanoclavine aldehyde.  Rotation 
around this bond can occur spontaneously, but most likely occurs at a slow rate.  This can 
be observed in the dramatic difference in accumulation between easA ko and Cp easA ct 
strains.  The much smaller quantities of agroclavine and setoclavine and isosetoclavine 
observed in the easA ko prior to complementation are hypothesized to arise after 
noncatalyzed isomerization in the enol tautomer of chanoclavine aldehyde, more of 
which must accumulate in the easA ko (Fig. 3 & 8). 
 Interestingly, N. lolii, E. festucae, and C. fusiformis, all agroclavine producers, 
have phenylalanine at position 196, whereas those which synthesize festuclavine, such as 
C. gigantea and C. africana, have a tyrosine at this specific residue.  Notably, A. 
fumigatus easA is most distant from the easA homologues of other festuclavine 
producers, C. africana and C. gigantea.  Therefore, even though the presence of the Y196 
is common among all festuclavine producers, there are other differences among the easA 
sequences affecting their phylogenetic relationships (Fig. 5 & 6).   
 The gene easA is believed to be the branch point between the two lineage-specific 
pathways, making chanoclavine aldehyde the last common intermediate.  Whether the 
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presence of tyrosine or phenylalanine at the amino acid residue 196 is the only basis for 
production of festuclavine versus agroclavine still needs to be investigated further.    
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FIGURE LEGENDS 
Figure 1:  Examples of ergot alkaloids.  Festuclavine is in the clavine class of alkaloids 
and is synthesized by A. fumigatus, whereas ergotamine is an ergopeptine, and is 
produced by Claviceps spp.  The letters, A-D, labeled within festuclavine, identify the 
four rings common to ergot alkaloids.  The atoms within this four ring structure are 
numbered 1-15. 
 
Figure 2: easA ko disruption strategy.  (A) Knockout construct, pAFOYE1, contains 
an internal fragment of easA and was linearized at SmaI site prior to transformation.  This 
diagram shows tandem integration of three constructs within ko. UF = annealing site for 
primer derived from universal primer sequences in vector; 3S = annealing site for primer 
flanking the 3' border of integration site; UR= annealing site for primer derived from 
reverse primer sequences in vector; 5S = annealing site for primer flanking the 5' border 
of integration site.  (B) Primers 5S and 3S primed amplification of a 1.0-kb fragment only 
in the wild-type isolate.  Primers UR and 5S primed amplification of the expected 0.8-kb 
band from strains with disrupted easA allele but not from the wild type. Primers UF and 
3S primed amplification of the indicated 1.0-kb product from easA ko and easA 
complemented (easA ct).  Relative mobility of relevant fragments (sizes in kb) of BstEII-
digested bacteriophage lambda is indicated. (C) Integration of transforming DNA at only 
the targeted site was confirmed by Southern blot hybridization.  DNA extracts were 
digested with SalI and hybridized with a digoxigenin-dUTP labeled easA probe. 
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Figure 3: Chromatogram of wild-type A. fumigatus (wt), easA ko, and easA ko 
complemented with a functional copy of C. purpurea easA (Cp easA ct).  B = 
fumigaclavine B; F = festuclavine; A = fumigaclavine A; C = fumigaclavine C; I = 
isosetoclavine; S = setoclavine; AG = agroclavine; CH = chanoclavine.  Excitation and 
emission wavelengths are provided in the upper left corner of each chromatogram.  
 
Figure 4:  ESI-MS of A. fumigatus easA ko strain and its C. purpurea easA 
complemented strain.  (A) Mass spectrum of the major 32-min peak that accumulates in 
easA ko and coelutes with chanoclavine during HPLC analysis.  (B) Mass spectra of three 
fractions collected from HPLC analysis of extract from Cp easA ct.  The 44-min peak 
coeluted with agroclavine; the 39-min peak and 42-min peak coeluted with setoclavine 
and isosetoclavine, respectively.   
 
Figure 5:  Alignment of EasA sequences.  Partial protein sequences, EasA, for A. 
fumigatus, C. africana, C. fusiformis, C. gigantea, C. purpurea (P1 and 20102), E. 
festucae, and N. lolii, were aligned by ClustalW.  The residue of interest (highlighted in 
yellow) corresponding to the active site tyrosine (Y) is as expected for A. fumigatus, C. 
africana, and C. gigantea, whereas all remaining sequences have a phenylalanine (F) at 
this position. 
 
Figure 6:  Distance analysis of EasA homologues among ergot alkaloid producers.  
(A)  Distance matrix based on alignment of EasA sequences.  The furthest distance is 
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between A. fumigatus and C. gigantea.  (B)  Unrooted Neighbor-Joining tree derived 
from the distance matrix calculated from aligned EasA sequences.   
 
Figure 7: The branch point of the ergot alkaloid pathway. The pathways diverge after 
chanoclavine aldehyde, due to the differing enzymatic properties of easA.  The easA 
product in A. fumigatus reduces the vinyl group in chanoclavine aldehyde, allowing 
rotation of the aldehyde group into close proximity of the N-methyl group for ring 
closure.  The product of C. purpurea easA only temporarily reduces the double bond 
resulting in formation of agroclavine instead of festuclavine.  Setoclavine and its isomer 
are readily produced from agroclavine by peroxidases from multiple sources, in this case 
presumably endogenous A. fumigatus peroxidases (16).  DMAPP = 
dimethylallylpyrophosphate; PPO = pyrophosphate; Trp = tryptophan; AdoMet = S-
adenosylmethionine; DMAT = dimethylallyltryptophan. 
 
Figure 8:  Model for noncatalyzed closure of D ring via keto-enol tautomerism.  
Chanoclavine aldehyde undergoes movement of electrons within its double bonds, 
creating the intermediary enolate ion, which acquires hydrogen from solvent to form enol 
tautomer.  This change in double bond location allows rotation around the alpha carbon, 
positioning the hydroxyl group within close proximity to the amine group.  Loss of the 
proton and reformation of the aldehyde creates isochanoclavine aldehyde.  The carbonyl 
group interacts with the amine group, and water is lost, resulting in closure of D ring as 
an iminium ion.  An additional NADPH-dependent reductase is required to reduce the 
iminium ion to agroclavine (17). 
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Table 1.  Accumulation of agroclavine, setoclavine, and isosetoclavine 
in A. fumigatus easA ko and A. fumigatus easA ko complemented with 
C. purpurea easA 
 Fg ergot alkaloid per conidium (mean ± standard error) 
Source Agroclavine 1 Setoclavine / Isosetoclavine 
wild type nd 2 nd 
easA ko 0.0095±0.0027a 0.012± 0.0019a 
Cp easA ct 1.1±0.082 b 1.4±0.090b 
  1Comparison of easA ko and Cp easA ct data within each column of table  
  by Wilcoxon/Kruskal-Wallis Tests; means with different letter indicate  
  significant difference (H = 6.8, d.f. = 1, P = 0.009). 
  2 nd, none detected  
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Neotyphodium_lolii              HKLVLSPMTRFRADNEGVPLPYVKTYYCQRASLPGTLLLTEATAISRRAR 50 
Epichloe_festucae               HKLVLSPMTRFRADNEGVPLPYVKTYYCQRASLPGTLLLTEATAISRRAR 50 
Claviceps_gigantea              HKIVLSPMTRIRADDHGVPLPYVKTYYAQRACVRGTLLITEAVAVCPRAK 50 
Claviceps_africana              HKIVLSPMTRIRADDDGVPLPCVQTYYAQRASVRGTLLITEAVAICPRAK 50 
Claviceps_purpurea_P1           HKIVLSPMTRFRADDNGVPLSYMKTFYAQRASVRGTLLVTDAVAICPRTK 50 
Claviceps_purpurea_20102        HKIVLSPMTRFRADDNGVPLSYMKTFYAQRASVRGTLLVTDAVAICPRTK 50 
Claviceps_fusiformis            HKVVLSPMTRFRADNDGVPLSYVKSYYGQRASIRGTLLITEAVAICPRAK 50 
Aspergillus_fumigatus           HRMIMAPTTRFRADGQGVPLPFVQEYYGQRASVPGTLLITEATDITPKAM 50 
                                *:::::* **:***..****. :: :* ***.: ****:*:*. :  ::  
 
Neotyphodium_lolii              GFPNVPGIWSQEQIAGWKEVVDAVHAKGSYIWLQLWATGRAAEVGVLKAN 100 
Epichloe_festucae               GFPNVPGIWSQEQIAGWKEVVDAVHAKGSYIWLQLWATGRAAEVGVLKAN 100 
Claviceps_gigantea              GLPNIPGIWSDSQIAAWKDVVDEVHSMGCSIWIQLWATGRASEMETLSSL 100 
Claviceps_africana              GIPNIPGIWNHDQMVAWKEVVDQVHARGCFIWVQLWATGRASEMETLRRN 100 
Claviceps_purpurea_P1           GFPNVPGIWHKDQIAAWKEVVDEVHSKGSFIWLQLWATGRAADLEALTSQ 100 
Claviceps_purpurea_20102        GFPNVPGIWHKDRIAAWKEVVDEVHSKGSFIWLQLWATGRAADLEALTSR 100 
Claviceps_fusiformis            GFSNCPGIWHQDQIAAWKEVVDEVHSKGSVIWLQLWATGRASDADTLKES 100 
Aspergillus_fumigatus           GYKHVPGIWSEPQREAWREIVSRVHSKKCFIFCQLWATGRAADPDVLADM 100 
                                *  : **** . :  .*:::*. **:  . *: ********::  .*    
 
Neotyphodium_lolii              GFDLVSSSAVPVSPGEPTPRALSDDEINSYIGDFVQAAKNAVLEAGFDGV 150 
Epichloe_festucae               GFDLVSSSAVPVSPGEPTPRALSDDEINSYIGDFVQAAKNAVLEAGFDGV 150 
Claviceps_gigantea              GFELESSSDVPIASGDPVPRPLSSEDIQLYIREYAQAARNAVHGAGFDGV 150 
Claviceps_africana              GFELESSSDVPIAAGDAVPRPLSDQDIQAYIREYAQAARNAVHGAGFDGV 150 
Claviceps_purpurea_P1           GLKLESSSEVPVAPGEPTPRALDEDEIQQYILDYVQGAKNAVHGAGFDGV 150 
Claviceps_purpurea_20102        GLKLGSSSEVPVAPGEPTPRALDEDEIQQYILDYVQGAKNAVHGAGFDGV 150 
Claviceps_fusiformis            GFHLESSSDVPVAPGEPVPRPLSEDEIESYIRDYVTGAINAVQGAGFDGI 150 
Aspergillus_fumigatus           K-DLISSSAVPVEEKGPLPRALTEDEIQQCIADFAQAARNAIN-AGFDGV 148 
                                  .* *** **:    . **.* .::*:  * ::. .* **:  *****: 
 
Neotyphodium_lolii              ELHGANGFLIDQFLQSPCNQRTDQWGGCIENRSRFGLEITRRVIDAVGKD 200 
Epichloe_festucae               ELHGANGFLIDQFLQSPCNQRTDQWGGCIENRSRFGLEITRRVIDAVGKD 200 
Claviceps_gigantea              EIHGAHGYQIDQFLQSSCNRRTDKWGGSIPGRSKFGLDITQSIIDAVGKD 200 
Claviceps_africana              EIHGAHGYQVDQFLQSSCNRRTDGWGGSIPARSRFGLDVVRSVIDAVSKD 200 
Claviceps_purpurea_P1           EIHGANGFLIDQFLQSSCNRRTDQWGGSIENRSRFGLEITRGVVDAVGHD 200 
Claviceps_purpurea_20102        EIHGANGFLIDQFLQSSCNRRTDQWGGSIENRSRFGLEITRGVVDAVGHD 200 
Claviceps_fusiformis            EIHGANGFLVDQFLQASCNTRADQWGGSIENRSRFGLEITRRVVDAVGKD 200 
Aspergillus_fumigatus           EIHGANGYLIDQFTQKSCNHRQDRWGGSIENRARFAVEVTRAVIEAVGAD 198 
                                *:***:*: :*** * .** * * ***.*  *::*.:::.: :::**. * 
 
Neotyphodium_lolii              HVGMKLSTWSTFQGMGTMDDLIPQFEHFIMRLREIGIAYLHLANSRWVEE 250 
Epichloe_festucae               HVGMKLSTWSTFQGMGTMDDLIPQFEHFIMRLREIGIAYLHLANSRWVEE 250 
Claviceps_gigantea              RVGMKLSPWSTFQGMGTMVDLLPQFQHFITCLREMDIAYLHLTNSRWLQE 250 
Claviceps_africana              RVGVKLSPWSTFQGMGTMDDLVPQFQHFISRLREMDVAYLHLTNSRWLQE 250 
Claviceps_purpurea_P1           RVGMKLSPWSTFQGMGTMDDLVPQFEHFITCLREMDIAYLHLANSRWVEE 250 
Claviceps_purpurea_20102        RVGMKLSPWSTFQGMGTMDDLVPQFEHFITCLREMDIAYLHLANSRWVEE 250 
Claviceps_fusiformis            RVGVKLSPWSTFQGMGTMDDLVAQFEHFISRLREMDIAYIHLVNTRWLEE 250 
Aspergillus_fumigatus           RVGVKLSPYSQYLGMGTMDELVPQFEYLIAQMRRLDVAYLHLANSRWLDE 248 
                                :**:***.:* : ***** :*:.**:::*  :*.:.:**:**.*:**::* 
 
Neotyphodium_lolii              EDPTIRTHPDIHNETFVRMWGKEKPVLLAGGYGPESAKLVVDETYSD-HK 299 
Epichloe_festucae               EDPTIRTHPDIHNETFVRMWGKEKPVLLAGGYGPESAKLVVDETYSD-HK 299 
Claviceps_gigantea              EQPGVKIHPDVNNATFVRMWGLEKPIVLAGGYDADSAKRLVDETYSE-HN 299 
Claviceps_africana              EQPGIKIHPDVHNATFVRMWGREKPIVLAGGYDADSAKRLVDETYSD-QN 299 
Claviceps_purpurea_P1           EDPSIRTHPDFHNQTFVQMWGKKRPILLAGGYDPDSARRLVDQTYSD-RN 299 
Claviceps_purpurea_20102        EDPSIRTHPDFHNQTFVQMWGKKRPILLAGGYDPDSARRLVDQTYSD-RN 299 
Claviceps_fusiformis            EEPGIKTHPDVDNQTFVRMWGNKTPILLAGGYDADSARRLVDETYSD-QN 299 
Aspergillus_fumigatus           EKP----HPDPNHEVFVRVWGQSSPILLAGGYDAASAEKVTEQMAAATYT 294 
                                *.*    *** .: .**::** . *::*****.. **. :.::  :   . 
 
Neotyphodium_lolii              NIGVVFGRHYISNPDLPFRLKMGLPLQKYNRET 332 
Epichloe_festucae               NIGVVFGRHYISNPDLPFRLKMGLPLQKYNRET 332 
Claviceps_gigantea              NVLVAFGRHYISNPDLPFRLKMGIALQKYNRDT 332 
Claviceps_africana              NVLVAFGRHYISNPDLPFRLKMGIALQKYNRDT 332 
Claviceps_purpurea_P1           NVLVVFGRHYISNPDLPFRLRMGIACRSTIETH 332 
Claviceps_purpurea_20102        NVLVVFGRHYISNPDLPFRLRMGIALQKYNRDT 332 
Claviceps_fusiformis            NIMVVFGRHYISNPDLPFRLRLGIPLQKYNRDT 332 
Aspergillus fumigatus NVAIAFGRYFISTPDLPFRVMAGIQLQKYDRAS 327
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Epichloë festucae
Neotyphodium lolii
Claviceps fusiformis
Claviceps purpurea 20102
Aspergillus fumigatus
Claviceps purpurea P1
Claviceps africana
Claviceps gigantea
Distance = 0.1
A
B
N.l.   E.f.   C.g.   C.a.   C.p C.p.   C.f. 
Neotyphodium_lolii
Epichloe_festucae 0.000  
Claviceps_gigantea 0.316  0.316
Claviceps_africana 0.313  0.313 0.136  
Claviceps_purpurea_P1       0.259  0.259 0.274  0.283  
Claviceps_purpurea_20102    0.241  0.241 0.256  0.265  0.033  
Claviceps_fusiformis 0.259  0.259 0.265  0.247  0.217  0.199  
Aspergillus_fumigatus 0.414  0.414 0.439  0.420  0.417  0.405  0.417
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CHAPTER 4: Association of ergot alkaloids with conidiation in 
Aspergillus fumigatus 
 
Published as: Coyle, C. M., S. C. Kenaley, W. R. Rittenour, and D. G. Panaccione.  2007. Mycologia 
99:804–811. 
ABSTRACT 
Ergot alkaloids are mycotoxins that affect the nervous and reproductive systems of 
exposed individuals through interactions with monoamine receptors.  They have been 
more widely studied in ergot fungi and grass endophytes but also are found in Aspergillus 
fumigatus, an opportunistic human pathogen that reproduces and disseminates 
exclusively through conidia.  The ergot alkaloids festuclavine and fumigaclavines A, B, 
and C are present in or on conidia of A. fumigatus.  Cultures of the fungus that are free of 
conidia are difficult to obtain, obscuring comparisons of conidia versus vegetative hyphae 
as sources of the ergot alkaloids.  To create conidiation-deficient strains of A. fumigatus, 
we manipulated the bristle A gene (brlA), which is a regulatory gene controlling vesicle 
formation or budding growth necessary for conidiation in Aspergillus spp.  Disruption of 
brlA in A. fumigatus, via homologous recombination, resulted in a non-conidiating 
mutant that produced bristle-like structures instead of conidiophores and conidia.  
Moreover, the disrupted strain failed to produce ergot alkaloids as verified by HPLC 
analyses.  Complementation with a wild-type allele restored conidiation and ergot 
alkaloid production.  These results suggest that ergot alkaloids are not produced within 
the vegetative mycelium of the fungus and are directly associated with conidiation.   
 
Key words: aspergillosis, bristle A gene, clavines, mycotoxins.  
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INTRODUCTION 
Ergot alkaloids are a complex family of indole-derived secondary metabolites produced 
by several fungi (15, 17, 23, 30).  The ecological roles of ergot alkaloids are poorly 
understood; however, they have activities against mammals, insects, nematodes, and 
bacteria (9, 10, 23, 24, 31).  Their effects on humans are thought to be mediated by their 
agonistic and/or antagonistic interactions with monoamine neurotransmitter receptors 
(17, 27, 28). 
Aspergillus fumigatus Fres., a common saprophyte and opportunistic pathogen, 
produces several ergot alkaloids, including festuclavine and fumigaclavines A, B, and C 
(13, 34, 37).  We recently reported a high-performance liquid chromatography (HPLC) 
procedure for identification and quantification of these alkaloids, and demonstrated them 
to be present in or on conidia of A. fumigatus in quantities that collectively total 
approximately 1% of the dry mass of the conidium (25).  Fumigaclavine C is the end 
product of the A. fumigatus pathway, with festuclavine, fumigaclavine B, and 
fumigaclavine A (in that sequence) acting as the final three intermediates in its 
biosynthesis (23, 30, 36).  Presumably, differences in abundance and activity of the 
enzymes responsible for converting one intermediate to the next account for the 
accumulation of festuclavine and fumigaclavine A to relatively high concentrations 
whereas fumigaclavine B is typically present in much lower concentrations (23, 25). 
In vitro, A. fumigatus sporulates prolifically and cultures free of conidia are very 
difficult to obtain.  Our unpublished observations of ergot alkaloid yields from cultures of 
A. fumigatus on agar-based media (primarily conidia and limited vegetative hyphae) 
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versus submerged, broth-based media (consisting mainly of hyphae and fewer conidia) 
suggested an apparent association between conidiation and ergot alkaloids.   
Previous research on Aspergillus spp. has associated secondary metabolism and 
sporulation (5, 7).  For example, sporulation and sterigmatocystin production have been 
shown to be regulated by a FadA Gα protein-dependent signaling pathway in Aspergillus 
nidulans Eidam (Winter) (18).  More specifically, sterigmatocystin production and 
conidiation are both negatively regulated by a cAMP-dependent protein kinase catalytic 
subunit (pkaA) (33).   
Conidiation has been studied extensively in A. nidulans.  Conidiophore 
development is contingent on differentiation of the fungus from polarized apical 
extension to budding growth (12).  One gene in particular, brlA, has been determined to 
control conidiophore development and encodes a nucleic acid binding protein (BrlA) (1, 
3, 6).  BrlA is an early protein in a signaling cascade that controls the expression of many 
genes, including some that encode for other regulatory proteins, by binding to brlA 
response elements (BREs) within the promoter regions of these genes (8).  In A. nidulans, 
transcription of brlA may initiate at different sites resulting in two overlapping 
transcription units, brlAα and brlAβ (29).  The products of these two forms are 
functionally interchangeable, translated in the same reading frame, and differ only in that 
the product of brlAβ has an additional 23 amino acids at the amino terminus (29).  In this 
paper, we report mutational analyses of the brlA gene of A. fumigatus to produce non-
conidiating mutants for the purpose of examining whether ergot alkaloids are produced 
during vegetative growth or conidiation. 
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MATERIALS AND METHODS 
Fungi and culture conditions.  Aspergillus fumigatus isolate FGSC A1141 (25) and 
derivatives were routinely cultured on potato dextrose agar (PDA) prepared from 
dehydrated potato flakes (Pillsbury, Minneapolis, MN)(20 g/L), D-glucose (20 g/L), and 
agar (15 g/L).  Cultures intended for preparation of protoplasts or DNA were grown 
overnight in 15 mL of malt extract medium (50 g malt extract, 50 g lactose, 5 g 
asparagine, and 0.4 g K2HPO4 per L) in a deep Petri dish (20-mm depth, 100-mm 
diameter; Fisher Scientific, Pittsburgh, PA) on an orbital shaker set at 37 ºC and 150 rpm.  
Non-conidiating mutants were cultured similarly except pieces of agar-based cultures 
containing hyphal fragments were used in place of conidia as inoculum.   
Disruption and complementation of brlA.  The presence of a brlA orthologue in 
the A. fumigatus genome (21) was determined by tblastn search with protein sequence 
deduced from A. nidulans brlA (1) as a query sequence.  A 640-bp fragment internal to 
the coding sequence of the putative brlA orthologue was amplified by PCR primed with 
oligonucleotides brlAF (5'-GCCACGCTTACGACAGAGGT-3') and brlAR (5'-
CGGTAGATAGGCGACTGGTG -3').  The 50 µL PCR reaction contained 50 mM KCl, 
10 mM Tris-HCl (pH 9.0), 0.1% (v/v) Triton X-100, 1.5 mM MgCl2, 200 µM of each 
deoxyribonucleotide triphosphate, 1 µM of each primer, and 2.5 units of Taq DNA 
polymerase (Promega, Madison, Wisconsin), which was added once the thermocycler 
reached 95 °C in the initial denaturing period.  The reaction began with an initial 
denaturing step of 2 min 30 sec at 95 °C, followed by 35 cycles of 1 min at 94 °C, 1 min 
at 57 °C, and 1 min at 72 °C, with a final extension step of 72 °C for 7 min.  A 4.6-kb 
disruption construct, pBRLA1, was generated by ligating the PCR product into the T/A 
113 
 
overlap vector pCR2.1 (Invitrogen, Carlsbad, California).  The construct was linearized at 
the unique NdeI site located within the brlA fragment prior to transformation of the 
fungus.  Protoplasts were prepared and transformed according to the protocol described 
by Murray et al. (20) and with modifications noted previously (14).  Protoplasts were co-
transformed with the linearized disruption construct, pBRLA1, and a hygromycin 
resistance plasmid, pMOcosX (22), linearized at a unique NotI site (14).  Non-conidiating 
transformants were identified by their altered colony morphology and color, and were 
confirmed by light microscopy.  Non-conidiating mutants were purified to nuclear 
homogeneity through repetitive sub-culturing from hyphal tips (since nuclear purification 
via single conidium isolation was not possible).  Homologous recombination between 
pBRLA1 and the native brlA locus within the transformants was verified by three PCR 
assays similar to the PCR reaction described above but with different primers and 
annealing temperatures.  The 5' border of the recombination event was confirmed by PCR 
(annealing temperature at 57 °C) primed with oligonucleotides UF (5'-
TGTAAAACGACGGCCAGTGAAT-3', which anneals to vector sequences near the 
universal primer annealing site in pCR2.1) and brlAFscrn (5'-
CTCCAACGAATGTCCGTCTATG -3', complementary to brlA sequences near the 5'-
end of the brlA gene and flanking the intended site of integration) (Fig. 1A).  The 
juxtaposition of sequences near the 3' border of the integration event was verified by PCR 
(annealing temp 55 °C) primed from oligonucleotides UR (5'-
AGCTATGACCATGATTACGCCA-3', complementary to vector sequences near the 
reverse primer annealing site of pCR2.1), and brlARscrn (5'-
TAGTGACAAGCTCTGCTTGGA -3', which anneals to brlA sequences near the 3'-end 
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of the gene and flanking the intended site of integration) (Fig. 1A).  PCR across the entire 
brlA locus was conducted by priming with oligonucleotides brlAFscrn and brlARscrn 
(both described above) at an annealing temperature of 55 °C.   
Integration of the transformation construct also was analyzed by Southern 
hybridization as described previously (14), except for substitution of a brlA-specific 
probe.  The brlA probe was made by amplifying wild-type A. fumigatus genomic DNA 
via PCR from primers brlAF and brlAR, according to the PCR conditions described 
above, substituting 1× DIG DNA Labeling Mix (Roche, Mannheim, Germany) for 
unlabeled dNTPs, and increasing the annealing temperature to 57 °C. 
The brlA ko strain was complemented with a 2.9-kb fragment containing a full-
length copy of the brlA coding sequences along with approximately 1 kb of 5'-flanking 
sequences and 0.6 kb of 3'-flanking sequences.  The complementing fragment was 
amplified by PCR primed from WbrlAF (5'-
CTCTCCAGGAACCTTGAAACAGGTTCTC-3') and WbrlAR (5'-
CCACATAGGACACTCGAGGATGGAGACA-3') in a 50 µL PCR reaction containing 
15 mM (NH4)2SO4, 50 mM Tris-HCl (pH 9.0), 0.1% (v/v) Triton X-100, 1.5 mM MgCl2, 
200 µM of each dNTP, 1 µM of each primer, and 1 unit of DyNAzyme DNA polymerase 
(New England Biolabs, Beverly, MA) added during the initial denaturing step.  The 
thermocycler program was as described above; however, the annealing temperature was 
62 °C and the extension step was for 3 min 20 sec.  The PCR product was cotransformed 
into a brlA-disrupted mutant along with a phleomycin resistance plasmid, pBC-phleo 
(Fungal Genetics Stock Center, University of Missouri-Kansas City, Kansas City, MO).  
Transformants were selected on complete regeneration medium (26) containing 100 
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µg/mL phleomycin and incubated at 37 °C.  Complemented transformants were cultured 
from individual germinated conidia in order to achieve a homokaryotic culture.  To test 
for the presence of the original disruption construct, PCR reactions were initiated from 
primers brlAFscrn and UF (for the 5' flank of the integration) and UR and brlARscrn (for 
the 3' flank).  An additional PCR screen was performed with primers WbrlAF and 
WbrlaR (described above), to test for the presence of the introduced wild-type allele in 
the complemented transformants.  PCR conditions are provided above with descriptions 
of the primers (above).   
Analysis of ergot alkaloids and conidiation.  For routine analysis of ergot 
alkaloids, small cubes of cultures grown on PDA (containing approximately 8 mm x 8 
mm of colony surface area) were submerged in 0.5 mL of 80% methanol in a 1.9-mL 
microcentrifuge tube and pulverized with a plastic pestle.  The samples were rotated, end 
over end (44 rpm), for 2 hr, and spin-filtered through a 0.2-µM pore nylon filter.  Ergot 
alkaloids were detected and quantified from 20 µL of the prepared sample by reverse-
phase HPLC on a C18 column with fluorescence detection based on excitation and 
emission wavelengths of 272 nm and 372 nm, respectively (25).  The identities of peaks 
corresponding to festuclavine, and fumigaclavines A, B, and C were previously 
established by mass spectral analyses of native and de-esterified fractions (25) and 
confirmed by elimination of these peaks from extracts of strains in which the first gene in 
the ergot alkaloid pathway (dmaW) was inactivated by gene disruption (14).   
 To quantify ergot alkaloids and conidiation from the same samples, cultures were 
gown on PDA for 5 days at 37 °C and then an additional 9 days at room temperature.  
Samples containing 50.3 mm2 of colony surface area were extracted from cultures with 
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the broader end of a disposable 1-mL pipette tip (Fisher Scientific, catalog number 02-
681-172).  Samples were submerged in 1 mL 80% methanol, agitated by vortexing, and 
rotated at 44 rpm for 2 hr.  Separate aliquots were removed for HPLC analyses and for 
quantification of conidia.  Concentrations of ergot alkaloids were based on peak area 
relative to an external standard of agroclavine (Sigma, St. Louis, MO) as previously 
described (25).  Conidia were enumerated in dilutions of the methanol extracts with a 
hemacytometer and light microscope.  Six samples were analyzed for each treatment.  
Data from wild type and a complemented brlA disruptant were compared by Student’s t-
test.   
RESULTS 
Disruption and complementation of brlA.  The A. fumigatus genome contains an 
orthologue of brlA (GenBank accession XM_747933).  The sequence located on 
chromosome 1 between nucleotides 2258000 and 2259280 was predicted to encode a 
protein that is 68% identical to BrlAα from A. nidulans (19).  Based on sequence 
analysis, there is no evidence for capacity to encode the alternate BrlAβ product that has 
been observed in A. nidulans (29).  BrlAβ of A. nidulans is transcribed from the same 
locus as BrlAα and is identical to BrlAα except for containing an additional 23 amino 
acids at the amino terminus.  In A. fumigatus only 2 of 19 amino acid residues preceding 
the initiator methionine of BrlAα are identical to those in the analogous positions of 
BrlAβ of A. nidulans.  A fragment of A. fumigatus DNA corresponding to nucleotides 
191 to 830 of the BrlAα coding sequence of A. nidulans was used to direct homologous 
recombination of the gene disruption construct pBRLA1 at the brlA locus of A. fumigatus 
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(Fig. 1A).  Homologous recombination of pBRLA1 at brlA would interrupt coding 
sequences common to both brlAα and brlAβ (if it were to occur) in A. fumigatus.   
Cotransformation of pBRLA1 and NotI-linearized pMOcosX into A. fumigatus 
resulted in five non-sporulating colonies out of a total of 93 hygromycin-resistant 
transformants.  Agar-based cultures of the putative brlA disruption strains were white and 
fluffy, unlike the dense, sooty, dark-green appearance of wild-type cultures (Fig. 2A).  
Observed by light microscopy, the non-conidiating cultures had extensive, bristle-like, 
aerial hyphae that lacked the swollen apical vesicles, phialides, and conidia of mature 
conidiophores (Fig. 2B).  Putative disruptants that had been sub-cultured from hyphal tips 
six times in an effort to achieve a homokaryotic culture were analyzed by PCR and 
Southern blot hybridization.  Amplification of transformant DNA annealed to primer sets 
UF and brlAFscrn resulted in an 899-bp product (Fig. 1).  Similarly, PCR from UR and 
brlARscrn produced an 863-bp product.  Products of these sizes from transformants but 
not from the wild type indicated integration of the disruption construct into the native 
copy of brlA (Fig. 1).  The lack of a PCR product from these transformants when 
amplification was primed from brlAFscrn and brlARscrn indicated the absence of a wild-
type copy of brlA.  Integration of one or more copies of pBRLA1 at brlA results in a large 
distance between priming sites, whereas in the wild type the primer annealing sites are 
separated by only 910 bp (Fig. 1).  Moreover, the absence of a product in the brlA 
disrupted strains (Fig. 1B) indicated nuclear homogeneity of these strains, since any wild-
type nuclei in the colony would provide template for amplification of the 910-bp product.  
Southern blot analyses confirmed the presence of multiple disruption constructs within 
brlA, which is evident by a large shift in the size of the AccI fragment containing the 
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targeted gene region (Fig. 1C).  The lack of multiple bands hybridizing to transformant 
brlA ko17 on the Southern blot verified that random integration of constructs elsewhere 
in the genome had not occurred (Fig. 1C).   
Disrupted strain brlA ko17 was cotransformed with a 2.9-kb PCR product 
containing the wild-type brlA allele and NotI-linearized pBCphleo.  Six conidiating, 
phleomycin-resistant transformants were analyzed by PCR.  The presence of a wild-type 
copy of brlA in the conidiating transformants was demonstrated by the presence of a 2.9-
kb product in reactions primed with WbrlAF and WbrlAR (Fig. 3).  Additional PCR 
analyses of the brlA locus in the complemented strains indicated that pBRLA1 was still 
present at the previously disrupted brlA locus, since products of the predicted size were 
amplified from primer pairs flanking the site of integration of pBRLA1 (Fig. 3).  Thus the 
complementing wild-type brlA fragment had integrated at a locus other than the native 
brlA, and the recipient strain was derived from a brlA disruptant.  Similar quantities of 
conidia were produced by a brlA-complemented disruptant and the wild type (Table 1).   
 
Analysis of ergot alkaloid production in brlA-disrupted mutants and complemented 
derivatives.  Mycelia of brlA-disrupted mutants contained no detectable ergot alkaloids 
(Fig. 4, Table 1).  In contrast, conidiating colonies of wild-type and the brlA-
complemented strain accumulated festuclavine, and fumigaclavines A, B, and C in 
quantities that were similar by strain (Fig. 4, Table 1).  The relatively large peak eluting at 
53 minutes in the brlA ko17 profile represents a metabolite associated with hyphae.  It is 
present in low levels in wild-type and complemented extracts (Fig. 4), which come from 
colonies that contain abundant conidiophores and conidia but limited hyphae.  Its 
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presence in ergot alkaloid-deficient strains derived by knocking out the gene dmaW (14) 
indicates that it is unrelated to ergot alkaloids.   
Examination of the promoter region of ergot alkaloid cluster genes for bristle 
A response element (BRE) sequences.  Since ergot alkaloids were only produced in 
cultures expressing a functional brlA, the chromosomal region containing 11 genes from 
easA to easF of the ergot alkaloid gene cluster (14, 30)was examined for the BRE 
sequence, 5'-(C/A)(A/G)AGGG(G/A)-3' (8), and its 26 occurrences were mapped (Fig. 5).  
Given the degenerate nature of the BRE sequence and its ability to function in both 
orientations, it will occur by chance once in every 1024 bp of random sequence.  BREs 
occurred once every 1404 bp in the coding sequences, whereas in the 5' non-coding 
regions these elements occurred once every 409 bp, making BREs about 3.4 times more 
common in the 5' non-coding regions.  As assessed in a paired t-test, BREs occurred at a 
higher frequency per bp in 5' non-coding sequences than in the corresponding coding 
sequences (P = 0.03).  However, there were no occurrences of the BRE sequences 
upstream of three of 11 genes, including dmaW, the gene controlling the first step in the 
ergot alkaloid pathway (Fig. 5).  Six other genes had less than three BREs within their 
upstream non-coding sequences.  One 5' non-coding region contained four BRE 
sequences, and due to divergent orientation of genes, this non-coding sequence was part 
of the promoter region of two ergot alkaloid cluster genes.    
DISCUSSION 
Disruption of brlA in A. fumigatus resulted in a non-conidiating mutant lacking any 
recognizable conidiophores.  A similar phenotype has been reported recently by Mah and 
Yu (19) for brlA mutants of A. fumigatus constructed by a different knockout strategy.  
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The absence of ergot alkaloids in our non-conidiating mutants indicates that ergot 
alkaloids are not produced during vegetative growth and are solely associated with 
conidiation in A. fumigatus.  
The phenotype of the A. fumigatus brlA mutants indicates that brlA functions 
similarly in A. fumigatus as it does in A. nidulans.  brlA was first discovered as the 
Mendelian locus defective in mutants that failed to conidiate but instead grew bristles 
reaching lengths 20-30 times the normal conidiophore length (11).  The wild-type allele 
was cloned by complementation of the brlA mutant via transformation and recovery of 
the transforming DNA (35).  Adams et al. (1) demonstrated that expression of brlA under 
conditions that typically repress conidiation in A. nidulans (submerged broth culture) 
resulted in production of structures that produced conidium-like cells.  Two 
developmentally regulated genes downstream of brlA, abaA and wetA, were not 
expressed in the nonfunctional brlA mutant but were transcribed in the modified strains 
expressing brlA.  Furthermore, disruption of Cys2-His2-Zn(II) coordination sites resulted 
in the inability of BrlA to induce the conidiation pathway, thus supporting the 
functionality of BrlA as a transcription factor that requires two zinc fingers to bind DNA 
(2). 
Links between sporulation and secondary metabolite production in Aspergillus 
spp. have been demonstrated by mutational analyses of other genes that regulate 
sporulation (5, 7).  Relevant studies in A. fumigatus include work done on the regulatory 
genes stuA (32) and laeA (4).  Strains mutated at stuA produced conidiophores that were 
stunted, and appeared as vesicles that lacked phialides and arose directly from septate 
hyphae (32).  In microarray analysis, stuA mutants showed changes in expression levels 
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of genes in two separate gene clusters that are hypothesized to control production of 
unidentified secondary metabolites.  Numerous other genes were affected, including 
those encoding and proteins involved in development and morphogenesis, such as the cell 
wall protein, PhiA, and a sexual development repressor protein, Pro1.  Mutation of laeA 
impaired conidiophore (and conidium) development in broth cultures of A. fumigatus but 
laeA mutants conidiated normally on agar-based media.  LaeA regulates expression of 
genes involved in conidiophore and rodlet formation as well as genes involved in 
production of secondary metabolites such as gliotoxin (4).   
 Whether BrlA directly regulates the ergot cluster genes or whether those genes are 
controlled by a factor or factors whose expression depends upon brlA has not been 
established.  Over all, BREs were more abundant in the 5′ non-coding sequences 
compared to their corresponding coding sequence.  However, the brlA response element 
was absent from the 5' non-coding sequences of three ergot alkaloid cluster genes 
(including dmaW) and was present in only one or two copies upstream of six other genes.  
Chang and Timberlake (8) found that at least three BREs must be present in the upstream 
region to increase transcript accumulation from that gene.  The occasional absence and 
relatively low copy number of the BRE associated with ergot cluster genes indicates that 
factors controlled by or in addition to BrlA regulate the ergot cluster genes.  Previous 
work demonstrates that among the genes controlled by BrlA are genes encoding other 
regulatory factors such as AbaA and WetA (1, 6).  A global analysis of gene expression 
in a brlA mutant compared to wild type, revealing the genes and secondary metabolite 
gene clusters controlled by brlA, is already in progress (D.C. Sheppard, McGill 
University, personal communication).   
122 
 
Association of ergot alkaloids with conidiation may provide insight into the 
ecological significance and utility of these toxins to the fungus.  When A. fumigatus 
grows pathogenically, its hyphae colonize host tissue, and conidia are not produced (16).  
Because ergot alkaloids are not produced in hyphae, it is unlikely that they contribute to 
the invasive phase of aspergillosis.  Conidia are produced during saprophytic growth and 
serve primarily for dissemination.  Due to their exceptionally small size and low specific 
gravity (25), conidia can be inhaled deeply into the lungs of humans and animals.  To 
initiate infection, conidia must survive the initial host-defense response.  The possibility 
that ergot alkaloids contribute to increasing the survival of inhaled conidia remains to be 
investigated.  
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FIGURE LEGENDS 
Figure 1:  Homologous recombination at brlA.  (A) Primers brlAF and brlAR prime 
amplification of a 640-bp internal fragment from brlA.  Gene disruption construct 
pBRLA1 contains the internal fragment of brlA and was linearized at a unique NdeI site 
prior to transformation.  The bottom panel shows integration of three copies of the 
disruption construct within brlA and the positions of primers used in PCR experiments to 
demonstrate integration at this locus.  (B) Homologous recombination of the transforming 
DNA at brlA was demonstrated by PCR with primer set brlAFscrn and UF confirming 
integration at the 5'-end of the gene and primer set UR and brlARscrn confirming 
integration at the 3'-end.  Amplification across the 5' and 3' junctions of integration 
resulted in 899-bp and 863-bp fragments, respectively.  Primer positions are shown near 
the bottom of part A.  The wild-type (wt) screen was a PCR primed from brlAFscrn and 
brlARscrn, and amplification does not occur from DNA that has disruption constructs 
within the intended site of integration due to the increase in template length.  PCR of 
non-transformed (wt) DNA gives a product of 910 bp.  (C) Integration of transforming 
DNA at the targeted site was confirmed by Southern blot hybridization.  Fungal DNA 
extracts were digested with AccI and hybridized with a digoxigenin-dUTP labeled brlA 
probe.  The large size of the brlA-containing fragments in strains brlA ko17 and brlA 
ko40 indicate three or more copies of pBRLA1 are present in the integration site.  The 
relative mobilities of relevant fragments of BstEII-digested bacteriophage lambda DNA 
are indicated on the left in panels B and C. 
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Figure 2: Morphology of brlA mutants.  (A) Cultures of A. fumigatus wild type (right) 
and brlA ko (left) on agar-based media.  (B) Light microscopy of the same cultures 
allows for comparisons of wild-type conidiophore development and spore production 
(right) versus bristle-like structures in brlA ko (left).  Scale bar represents 10 µm.   
 
Figure 3: PCR analyses of complemented transformant.  The presence of an introduced 
wild-type allele of brlA in the complemented strain (brlA ct) was shown by PCR with 
primer set WbrlAF and WbrlAR.  Retention of the disruption construct previously 
integrated at the original brlA locus was detected by PCR with primers flanking the 5'-
end of the integration site (brlAFscrn and UF) and primers flanking the 3'-end of the 
integration site (brlARscrn and UR).  Primer positions are shown in Fig. 1.  The relative 
mobilities of relevant fragments of BstEII-digested bacteriophage lambda DNA are 
indicated to the left of the photograph. 
 
Figure 4: HPLC traces of wild-type A. fumigatus (wt), a brlA disrupted strain (brlA 
ko17), and a complemented strain of brlA ko17 (brlA ct), to which a functional copy of 
brlA has been added.  Ergot alkaloids were extracted with 80% methanol and analyzed by 
reverse phase HPLC with fluorescence detection (excitation and emission wavelengths of 
272 nm and 372 nm, respectively).  B = fumigaclavine B; F = festuclavine; A = 
fumigaclavine A; C = fumigaclavine C. 
 
Figure 5: Occurrence of BRE sequences in the ergot alkaloid gene cluster.  This map 
shows the locations of the BRE sequence within 5′ non-coding regions (13), coding 
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regions (9), 3′ non-coding regions (3), and within an intron (1, marked with asterisk) of 
these genes.   
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Table 1.  Mean conidiation and ergot alkaloid production by strain (n=6) for the wild-type 
(wt), the complemented brlA knockout (brlA ct), and the brlA knockout (brlA ko17) with 
associated confidence intervals (α=0.05).   
 
Strain  
Conidia x 
106 / mm2 
Ergot alkaloid concentration (fg per conidium) 
Festuclavine 
 
Fumigaclavine 
A 
Fumigaclavine 
B 
Fumigaclavine 
C 
wt 1.3 (±0.6)a 10.2 (±2.7) 1.1 (±0.3) 0.2 (±0.0) 6.7 (±1.6) 
brlA ct 0.9 (±0.4) 15.2 (±6.3) 1.1 (±0.5) 0.3 (±0.2) 8.8 (±4.4) 
brlA ko17 ndb nd nd nd nd 
 
a Comparison of wt and brlA ct data within each column of table by t-test indicates no 
significant difference (P > 0.05). 
b none detected 
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SUMMARY AND FUTURE DIRECTIONS   
 
Ergot alkaloids are mycotoxins capable of interacting with neurotransmitter receptors and 
causing toxicoses.  However, they are also important metabolites that can be medicinally 
advantageous.  The ability to control the spectrum of alkaloids produced is contingent 
upon understanding how they are synthesized.  Aspergillus fumigatus may be a good 
model system to study ergot alkaloid biosynthesis compared to other ergot alkaloid 
producers.  Therefore this study focuses on ergot alkaloid production in A. fumigatus, 
examining specifically its association with sporulation and ergot alkaloid synthesis genes 
common to both A. fumigatus and ergot fungi. 
 In previous work, Dr. Panaccione had determined that ergot alkaloids were 
associated with the conidia of A. fumigatus.  Results of analyses of ergot alkaloid content 
of spores produced on different substrates indicated that these mycotoxins are present in 
relatively abundant concentrations regardless of medium.  Analysis of the physical 
properties of conidia of A. fumigatus and several other fungi showed that the spores of A. 
fumigatus are significantly smaller, lighter, and of lower specific gravity when compared 
to those of Aspergillus niger, Aspergillus nidulans, and Stachybotrys chartarum, a fungus 
of public concern  [(5); Appendix 1].  Investigations involving alkaloid accumulation in 
or on spores prompted a study of whether ergot alkaloids were produced only during 
sporulation.  Knockout of brlA, a gene known to be involved in sporulation in A. 
nidulans, demonstrated this gene to be involved in conidiation in A. fumigatus [(1); 
Chapter 1].  Lack of a functional BrlA rendered the fungus unable to form proper 
conidiophores (asexual sporulation structures) and devoid of spores.  This mutant also 
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lacked ergot alkaloids, thereby indicating that brlA does affect their production and that 
the ergot alkaloid pathway and the sporulation pathway are linked, which has also been 
recently demonstrated with some other secondary metabolites. 
 The second part of this research focused on understanding genes common to both 
A. fumigatus and ergot fungi that act early in the ergot alkaloid biosynthesis pathway.  
Annotation of the genomic region surrounding a homologue of dmaW, the gene 
controlling the determinant step in the ergot alkaloid pathway as demonstrated previously 
in studies with Neotyphodium sp. Lp1 (7), revealed the presence of a cluster of genes that 
potentially could be involved in ergot alkaloid biosynthesis [(2); Chapter 2].  Individual 
genes in the ergot alkaloid gene cluster and their potential involvement in ergot alkaloid 
production were investigated in a series of gene knockout experiments.  Knockout of the 
dmaW homologue in A. fumigatus eliminated all ergot alkaloid production in the fungus.  
This result is consistent with the role DMAT (dimethylallyltryptophan) synthase plays in 
Neotyphodium sp. Lp1.   
Knockout of other clustered genes, easA, easE, and easF, revealed their 
involvement in synthesis of these toxins.  This research suggested that easF and easE 
encode products involved in the second and third steps of the pathway, respectively.  The 
ergot alkaloid profile of easF knockout showed an accumulation of DMAT, due to the 
mutant’s inability to methylate it into N-methyl DMAT (Chapter 2), as well as small 
accumulations of downstream intermediates, such as festuclavine.  These observations 
imply that the product of easF N-methylates DMAT but that ergot alkaloid synthesis can 
occur very inefficiently even without EasF, given that DMAT synthase can prenylate 
abrine to form N-methyl DMAT (6).  The easE mutant accumulated an intermediate 
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characteristically similar to N-methyl DMAT and is presumed to act as an oxidase via 
adding an hydroxyl group onto this substrate.   
Lastly, easA was determined to encode a putative OYE oxidoreductase, and its 
product was found to be involved in synthesis of festuclavine from chanoclavine 
aldehyde in A. fumigatus.  The Claviceps purpurea homologue of easA catalyzed 
synthesis of agroclavine instead of festuclavine, which was evident from 
complementation of the C. purpurea easA into A. fumigatus easA knockout (Chapter 3).  
Protein sequence analysis revealed a key difference in a specific amino acid, which is 
known to be important in other OYEs for reduction of double bonds (3, 4).  Fungi that 
produce festuclavine contain a critical active site tyrosine, whereas those that synthesize 
agroclavine-derived alkaloids typical of ergot fungi (ergopeptines, etc) had phenylalanine 
at the corresponding position.  Therefore, differences in EasA function among 
homologues have been demonstrated to be responsible for the divergence of the pathway.   
 This study has demonstrated the coupling of ergot alkaloid production with 
sporulation.  Future research should focus on understanding where expression of these 
eas genes occurs.  Such results may allow us to link intermediates with specific cell types 
within A. fumigatus.  Also future research could focus on analysis of ergot alkaloid 
production in other sporulation mutants to further characterize the association between 
ergot alkaloid production and conidiation.   
 This research also has demonstrated the role of multiple eas genes previously 
hypothesized to be involved in ergot alkaloid biosynthesis.  The genes, easF and easE, 
control steps that occur early in the pathway and theoretically should function similarly in 
ergot fungi.  Future research should focus on delineating the roles of other clustered 
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genes, such as easD and easG, which are common between A. fumigatus and ergot fungi 
and may share a similar function in both pathways.  Additional, unassigned pathway 
steps that these genes may control include formation of the epoxide following the diene 
intermediate, chanoclavine aldehyde synthesis, or reduction of the imine, which results 
from closure of the fourth ring.  Further elucidation of the pathway will unveil the 
involvement of these and other genes within the eas gene cluster.   
 Since easA is the point of divergence for the pathway, the discovery of functions 
of later pathway genes from clavicipitaceous fungi might be discovered by adding 
candidate genes to the Cp easA-complemented A. fumigatus easA knockout.  Further 
characterization of the EasA homologues via point mutation analyses are necessary to 
understand the genetic basis for differences observed in their enzymatic functions. 
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common airborne fungus Aspergillus fumigatus 
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ABSTRACT 
Ergot alkaloids are mycotoxins that interact with several monoamine receptors, 
negatively affecting cardiovascular, nervous, reproductive, and immune systems of 
exposed humans and animals.  Aspergillus fumigatus, a common airborne fungus and 
opportunistic human pathogen, can produce ergot alkaloids in broth culture.  The 
objectives of this study were to determine if A. fumigatus accumulates ergot alkaloids in 
respirable form in or on its conidia, to quantify ergot alkaloids associated with conidia 
produced on several different substrates, and to measure relevant physical properties of 
those conidia.  We found at least four ergot alkaloids — fumigaclavine C, festuclavine, 
fumigaclavine A, and fumigaclavine B, in order of abundance — associated with conidia 
of A. fumigatus.  Under environmentally relevant conditions, the total mass of ergot 
alkaloids often constituted > 1% of the mass of the conidium.  Ergot alkaloids were 
extracted from conidia produced on all media tested, with the greatest quantities observed 
when the fungus was cultured on latex paint or cultured maize seedlings.  Physical 
properties of conidia likely to affect their respirability, i.e. diameter, mass, and specific 
gravity, were significantly lower in A. fumigatus than in Aspergillus nidulans, Aspergillus 
niger, and Stachybotrys chartarum.  Demonstration of relatively high concentrations of 
ergot alkaloids associated with conidia of A. fumigatus presents opportunities for 
investigations of potential contributions of the toxins to adverse health effects associated 
with the fungus and to aspects of the biology of the fungus that contribute to its success.   
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INTRODUCTION 
Ergot alkaloids are a complex family of indole-derived alkaloids that have a long history 
of association with human suffering.  The contamination of rye and other grain crops 
with alkaloid-rich sclerotia of the ergot fungus Claviceps purpurea was responsible for 
gangrenous and convulsive forms of ergotism known as St. Anthony’s fire or holy fire 
(19).  Other ergot alkaloid-producing fungi such as the closely related Neotyphodium spp. 
endophytes of forage grasses negatively affect agriculture by reducing animal 
productivity and health (2, 22).  The ability of different ergot alkaloids to act as partial 
agonists or antagonists of various serotonin, dopamine, and α-adrenaline receptors results 
in effects on nervous, circulatory, reproductive, and immune systems leading to high or 
low blood pressure, muscle contractions, reduced fertility, disturbances in sleep/wake 
cycles, lowered immune response, and, at high doses, hallucinations and gangrene of the 
extremities (14, 16, 22, 25, 31).     
Screens of other fungi for ergot alkaloids have identified several distantly related 
fungi as potential sources (13, 17, 29).  Among these fungi, the best characterized is 
Aspergillus fumigatus.  This fungus was first noted to produce the ergot alkaloid 
festuclavine and two novel derivatives of festuclavine named fumigaclavine A and 
fumigaclavine B in semidefined broth culture (29).  Later Cole et al. (3) described an 
additional festuclavine derivative, fumigaclavine C, from broth cultures of A. fumigatus 
originally isolated from moldy silage.   
Aspergillus fumigatus is associated with several human health issues.  It is the 
most common airborne fungal pathogen of humans (6, 18).  It can cause invasive 
aspergillosis in immunocompromised individuals, with resulting mortality at > 50%.  In 
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immunocompetent individuals, the fungus can colonize preexisting cavities in the lungs 
or sinuses without penetrating into tissues, a condition known as aspergilloma or fungus 
ball (6, 11, 18).  The fungus also is associated with air quality issues in indoor 
environments and near composting facilities (11, 12, 27).  Presence of conidia of A. 
fumigatus and of several other fungi in such environments has been loosely associated 
with respiratory allergic symptoms and miscellaneous other ailments, but causal 
associations have not been demonstrated. 
Most mycotoxin-producing fungi produce their toxins in the substrate in which 
they grow and ingestion of that contaminated substrate is required for intoxication.  
Although less frequently documented, the presence of mycotoxins in or on conidia of the 
producing fungus provides the potential for delivery of mycotoxins via the alternate and 
less voluntary route of inhalation.  For example, the black mold fungus Stachybotrys 
chartarum contains trichothecenes associated with its spores (28).   
Our objectives in this study were to determine if conidia of A. fumigatus contain 
ergot alkaloids in respirable form, to quantify ergot alkaloids associated with conidia 
produced on several environmentally relevant substrates, and to measure physical 
properties of conidia likely to affect their respirability.  Detection and quantification of 
ergot alkaloids associated with conidia is prerequisite to investigations of potential 
contributions of the alkaloids to adverse human health effects or to other aspects of the 
biology of the fungus.   
MATERIALS AND METHODS 
Fungi and culture conditions.  Aspergillus fumigatus isolate WVU1943 (FGSC) was 
cultured from the lungs of a deceased parakeet in Charleston, West Virginia, during 1977.  
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Isolate WVU2026 (FGSC) was obtained by passive sampling of the air (by opening a 
Petri dish of potato dextrose agar for 20 minutes under ambient conditions) in a house in 
Monongalia County, West Virginia, during 2003.  All viable cultures were manipulated 
in a class II biosafety cabinet.  Isolates were maintained on potato dextrose agar [PDA; 
20 g/L dehydrated mashed potatoes (Idaho Spuds, Pillsbury, Minneapolis, MN), 20 g/L 
glucose, 15 g/L agar (Bacto-Agar, Difco, Detroit, MI)] at room temperature or at 37 ºC, 
and most ergot alkaloid analyses were conducted on cultures grown on this medium.  
Additional alkaloid analyses were conducted with A. fumigatus isolates cultured on the 
following substrates: 1.5% (w/v) water agar plates (prepared with Difco Bacto-Agar); 
Pittsburgh Paint (Pittsburgh, PA) interior latex base 88-110 (low luster semigloss latex 
100% acrylic white and pastel mixing base) that had been applied with a brush in two 
thin layers on the inside of lids of Petri dishes and allowed to dry for 2 hr prior to 
inoculation; maize (Zea mays DeKalb hybrid DK626RR, DeKalb, IL) seedlings four days 
after germination of surface-sterilized kernels on water agar; and, water-rinsed and 
autoclaved pistachio (Pistacia vera; Blue Diamond, Sacramento, CA) shells.  Painted and 
inoculated Petri dish lids were placed over 1.5% water agar plates to promote high 
humidity for growth of the fungus.  Pistachio shells were incubated in Petri dishes 
containing 8 mL of sterile distilled water to promote high humidity.  Cultures were 
inoculated by lightly dusting the medium with conidia that had adhered to a Petri dish lid 
formerly covering a mature culture.  In mock inoculations, an average of 1.2 × 107 
conidia per Petri dish were deposited by this inoculation method.   
Large numbers of conidia, free of culture medium and hyphae, were collected 
from PDA cultures by tapping a culture dish such that conidia accumulated on the inside 
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of the lid.  In this way, alkaloids could be extracted exclusively from conidia.  
Alternatively, conidia could be made airborne from a Petri dish lid by agitating the lid by 
hand.  Airborne conidia were then collected on a 0.2-µm SFCA filter (Nalge Nunc 
International, Rochester, NY) or a 0.45-µm nylon filter (Millipore, Bedford, MA) under 
vacuum and extracted by washing the filter with 800 µl of 80% methanol.  In other 
experiments, conidia were collected from water agar and paint cultures by very briefly 
washing small portions of the sporulating cultures with 800 µL of 80% methanol.  
Conidia were harvested from corn or pistachio tissue by suspending pieces of the 
colonized and spore-bearing tissue in 1 mL of 80% methanol.  Microscopic examination 
of conidial suspensions prepared from any of these alternate substrates revealed the lack 
of hyphae.  However, with the exception of the conidia collected from PDA cultures, the 
extraction solvent had been briefly in contact with hyphae and the colonized substrate or 
medium.   
Stachybotrys chartarum and Aspergillus nidulans were isolated from 
contaminated building materials; Aspergillus niger was isolated by passive air sampling 
(as described above for A. fumigatus).  Conidia of these fungi, and of A. fumigatus, 
collected for measurement of their physical properties, were harvested with 80% 
methanol from cultures grown on PDA.  The number of conidia per mL of suspension 
was determined by counting dilutions on a hemacytometer (Hausser Scientific, Horsham, 
PA).  Conidia (of defined number) were collected by filtration though tared 0.22-µm 
nylon filters (Costar, Corning, NY) and retained for mass determination on a Mettler-
Toledo (Columbus, OH) AG104 balance after drying in a Labconco (Kansas City, MO) 
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centrivap concentrator.  Conidial diameter was determined microscopically with the aid 
of an ocular micrometer.   
HPLC, chemical manipulations, and mass spectrometry.  Aliquots of conidia 
were suspended in 80% methanol, transferred to 1.5-ml microcentrifuge tubes, and 
rotated end-over-end at 40 rpm for 1 hr on a Glas-Col (Terre Haute, IN) mini-rotator.  
The number of conidia in the extraction tube was determined by counting dilutions on a 
hemacytometer.  Conidia from PDA-based cultures were separated from the alkaloid 
extract by centrifugal filtration and weighed as described above.  For conidia derived 
from cultures on alternate substrates, conidial mass was calculated as the product of the 
number of conidia counted in the sample and the value previously calculated for mass of 
an individual conidium.  These calculations are based on the assumption that the mass of 
a conidium produced on these alternate substrates is the same as the mass of a conidium 
produced on PDA.   
Methanol extracts of conidia (with no further preparation beyond removal of 
conidia by filtration) were analyzed by HPLC with conditions described previously (23) 
except for changes in the equipment used.  The HPLC apparatus consisted of a model 600 
pump controller with in-line degasser, model 717plus autosampler, model 2487 
absorbance detector or model 996 photodiode array detector (all from Waters Corp., 
Milford, MA), and a Rainin (Woburn, MA) Fl2 fluorescence detector set with excitation 
and emission wavelengths of 272 nm and 372 nm, respectively.  Alkaloid quantities were 
determined based on comparison of peak areas relative to a standard curve derived from 
four dilutions each of three parallel samples of the highly similar ergot alkaloid 
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agroclavine (Sigma, St. Louis, MO) and adjusted for relative molecular weights of 
analytes and standard.   
For PDA-based cultures, several dilutions of each A. fumigatus spore extract were 
analyzed and the concentration of each alkaloid determined by linear regression analysis.  
Analyses of PDA-based cultures (Table 2) were conducted in triplicate on each of two 
separate occasions.  Three additional preliminary analyses yielded similar results.  
Extracts from A. fumigatus-colonized plant materials, water agar, or paint-based cultures 
(n = 3 to 6 / medium / isolate), which were less dense and contained fewer conidia than 
PDA-based cultures, were analyzed without dilution.  
Agroclavine was validated as a standard for the A. fumigatus clavines by 
comparing experimentally measured concentrations of it versus calculated concentrations 
of four separate preparations of dihydroergotamine and dihydroergocristine (Sigma), 
which carry the identical ergoline chromophore as the A. fumigatus ergot alkaloids.  
Concentrations of dihydroergotamine measured based on fluorescence relative to an 
agroclavine standard curve were 1.0 ± 0.04 (mean ± SE) times the calculated values, 
whereas the measured concentrations of dihydroergocristine solutions were 0.98 ± 0.05 
times the calculated values.   
The relationships among compounds represented in different peaks were 
investigated by deacetylation of alkaloid fractions with 1 M NaOH at room temperature 
for 15 hr (29).  Base-treated samples were neutralized with an equinormal solution of 
acetic acid and analyzed by HPLC as described above.  Masses of untreated and base-
treated compounds were obtained on a Finnegan Mass Spectrometer (model SSQ7000) at 
the WVU Mass Spectrometry Center.  Isolated peaks collected after HPLC were 
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concentrated 10-fold under vacuum, introduced into the ion source with an infusion 
pump, and ionized in positive electrospray ionization mode.   
Statistical Analyses.  Data were analyzed by analysis of variance, and means 
were compared by the Tukey-Kramer honestly significant difference test in the JMP 
software package (SAS Institute, Cary, NC).  Sets of values having unequal variances 
were log-transformed prior to analysis.   
RESULTS 
Identification and quantification of ergot alkaloids associated with conidia of A. 
fumigatus.  Several compounds from simple 80% methanolic extracts of conidia from 
PDA-cultured A. fumigatus produced large fluorescent peaks when analyzed by HPLC 
with excitation and emission wavelengths of 272 nm and 372 nm, respectively (Fig. 1).  
Electrospray ionization-mass spectrometry (ESI-MS) of the compound in peak C (Fig. 1), 
which had the greatest area and was the most nonpolar of the alkaloids analyzed, revealed 
an ion at m/z 367 corresponding in mass to [fumigaclavine C + H]+, which had previously 
been described from broth cultures of A. fumigatus (3).  Treatment of this compound with 
1 M NaOH resulted in a more polar compound (peak dC, Fig. 1) that yielded an ion at 
m/z 325, corresponding in mass to [deacetylated fumigaclavine C + H]+.   
Similarly the compound represented by peak A (Fig. 1) yielded an ion of m/z 299 
in its native form, consistent with a proposed identity as fumigaclavine A, and was 
converted after treatment with NaOH to a more polar compound (peak dA, Fig. 1) with 
an ion of m/z 257, consistent with [deacetylated fumigaclavine A + H]+.  Peak B, which 
cochromatographed with experimentally deacetylated fumigaclavine A (Fig. 1), is 
proposed to be fumigaclavine B, which is identical to deacetylated fumigaclavine A (3, 
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29).  Small quantities of fumigaclavine B also were detectable in untreated extracts of A. 
fumigatus conidia (peak B, Fig. 1).  The compound contained within peak F (Fig. 1) 
yielded an ion at m/z 241 in ESI-MS and was unaffected by NaOH treatment.  These 
characteristics are consistent with it being festuclavine, which had been characterized 
previously from culture extracts of A. fumigatus (29).   
Absorbance spectra of each of these compounds (data not shown) and their 
relative retention times on C18 silica were consistent with their proposed identities.  
Analyses of these same conidial extracts with an excitation wavelength of 310 nm and 
emission wavelength of 410 nm did not detect any of the previously characterized 
lysergyl-derived ergot alkaloids (not shown).  Conidia collected on the inner lid of a Petri 
dish and conidia aerosolized and collected on filters under vacuum yielded the same 
spectrum of ergot alkaloids.   
To relate quantities of ergot alkaloids to spore mass and investigate the buoyancy 
of A. fumigatus conidia, physical properties of conidia were measured (Table 1).  The 
conidia of A. fumigatus were significantly smaller, lighter, and less dense than those of 
some other common Aspergillus species and the black mold fungus S. chartarum (Table 
1).  [Although the ranges of diameter for conidia of Aspergillus species have been well 
established (26), we measured means and report them here so that calculations of density 
would be made from volume and mass of the same collections of conidia.]  Cultures of A. 
fumigatus on PDA sporulate abundantly; a two-month-old, 85-mm culture contained 5.8 
× 1010 conidia.   
Each of the four defined ergot alkaloids was quantified in extracts of defined 
conidium number and conidium mass (Table 2).  Ergot alkaloids accounted for 1.1% of 
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the mass per conidium of A. fumigatus isolate WVU1943 grown on PDA, whereas 
conidia of isolate WVU2026 appeared to contain slightly lower quantities of ergot 
alkaloids, though the difference was not statistically significant.  Both isolates 
accumulated the same array of ergot alkaloids when cultured on latex-based paint (Table 
2).  Isolate WVU2026 contained significantly more total ergot alkaloids on paint than it 
did on PDA; isolate WVU1943 also contained abundant total ergot alkaloid on paint but 
the increase relative to PDA was not statistically significant.  Colonies on paint were 
relatively small and consisted mainly of conidiophores and conidia with very little 
vegetative hyphae.  Cultures on water agar (also mostly conidiophores and conidia) still 
accumulated ergot alkaloids despite the limited exogenous nutrients in this medium.  
However, concentrations of ergot alkaloids extracted from the water agar-derived conidia 
were generally lower than those from conidia produced on the other substrates.  The same 
set of ergot alkaloids also was detected in or on conidia of cultures grown on cultured 
maize seedlings (on which the fungus colonized mainly the residual scutellum and kernel 
tissue), where they accumulated to relatively high levels, and on sterilized pistachio shells 
(on which the fungus grew poorly), where the concentrations of ergot alkaloids were 
relatively low (Table 2).    
The yield of ergot alkaloids recovered after a more harsh extraction procedure 
was assessed in a separate experiment.  Breaking of ~63% of the conidia by bead-beating, 
followed by a 1-hr extraction in 80% methanol resulted in a 38% increase in total ergot 
alkaloids relative to those extracted from unbeaten conidia.   
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DISCUSSION 
Our results demonstrate that high levels of certain ergot alkaloids are associated with 
conidia of A. fumigatus.  The alkaloids are present in or on conidia produced by cultures 
grown on a variety of substrates.  Moreover, the conidia of A. fumigatus are smaller, 
lighter, and less dense than those of closely related species.  These physical properties 
may promote the aerosolization and buoyancy of the conidia, which serve as vehicles for 
the alkaloids.   
Whether the ergot alkaloids are on the surface of the conidia, contained within the 
conidia, or in both locations cannot be answered definitively with the available data.  The 
majority of the ergot alkaloids were easily extracted from intact conidia, which suggests a 
surface location.  A bead-beating treatment that physically disrupted the spore wall 
increased the amount of alkaloid extracted by 38%.  However, in addition to cell 
breakage, this treatment also more vigorously extracts any surface compounds.  The data 
from this more disruptive extraction also indicate that the values listed in Table 2 
represent minimum values for conidium-associated alkaloids.  The question of location of 
the ergot alkaloids relative to the spore surface may not be significant from a health 
perspective.  In immunocompetent individuals, inhaled conidia are likely to be killed and 
lysed by macrophages (18), releasing any mycotoxins contained within.  Conidia that are 
not killed and lysed present a threat of infection and, likely, additional toxin production.  
A role for ergot alkaloids in invasive aspergillosis has not been investigated.  Such 
studies would be facilitated by comparison of wild-type isolates with the ergot alkaloid-
deficient mutants described in the accompanying paper (4).  In the absence of infection, 
conidia may serve as vehicles for exposure to ergot alkaloids. 
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The issue of health risks posed by inhalation of mycotoxin-containing conidia is 
complex and affected by several factors including the physical nature of the conidia with 
respect to their potential for dispersal and inhalation and the production of mycotoxins on 
environmentally relevant substrates.  The conidia of A. fumigatus have properties that 
appear to facilitate their dispersal and inhalation.  The 2.8-µm diameter of conidia is 
small enough for them to penetrate deep into the alveoli of the lungs (18).  The low 
specific gravity of the conidia (0.24) probably promotes efficient air dispersal.  For 
comparison, the conidia of the trichothecene producer S. chartarum, which have 
generated considerable health concerns (10, 28), have a mass that is 48 times greater and 
a specific gravity that is 4 times greater than those of conidia of A. fumigatus.   
Ergot alkaloids were detected on all tested media, including environmentally 
relevant substrates such as latex paint, two different plant materials, and water agar 
(representative of moist, nutritionally poor environments).  The reported concentrations 
of ergot alkaloids associated with conidia produced on substrates other than PDA are 
based on the number of conidia extracted and a value for conidial mass measured from 
conidia produced on PDA.  Thus, these values are based on the assumption that conidia 
produced on any of the alternate substrates have the same mass as conidia produced on 
PDA.  We contend that this is a reasonable assumption.  However, if the mass per 
conidium were, in fact, greater on a natural substrate than on PDA, then the calculated 
values of ergot alkaloid per conidium would be lower.  Conversely, if the conidial mass 
were lower on a natural substrate than on PDA, then alkaloid concentration would be 
greater than listed in Table 2.   
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A more complicated factor in determination of health risks associated with 
conidial mycotoxins is the issue of whether the toxins can or will be encountered in 
quantities sufficient for them to exert their effects.  There are at least three components to 
this issue, including (a) concentration of mycotoxin per conidium, (b) the number of 
conidia encountered, and (c) the toxicity of the mycotoxins. 
Concentrations of ergot alkaloids exceeding 1% by mass of A. fumigatus conidia 
are relatively high for fungal natural products.  There are few data available for direct 
comparison, because most mycotoxin analyses are expressed as mass of toxin per unit 
volume of culture.  Data on respirable trichothecenes from S. chartarum (28) indicate a 
mean of 17 ng of trichothecenes per mg of dust aerosolized from S. chartarum cultured 
on rice.  Assuming that conidia, which constituted 85% of the particles in the aerosolized 
dust (28), contribute 85% of the mass of the dust sample, then 0.002% of the conidium by 
mass was trichothecenes.  With a different isolate of this same fungal species and 
measuring only the most abundant trichothecene, Nikulin et al. (21) reported 0.1 pg of 
satratoxin H per conidium, which would translate to 0.0007% satratoxin H per mass of 
conidium.  Another source of alkaloid data per unit fungal mass comes from the 
poisonous mushroom literature.  For example, basidiocarps of Amanita muscaria contain 
ibotenic acid at 0.45% by mass dry weight and muscimol at 0.036% (30) [assuming 12.5 
mg fresh weight basidiocarp yields 1 mg dry weight (9)].  Amatoxins have been 
measured at 0.1% to 0.7% of the dry weight of Amanita phalloides basidiocarps (9).  In a 
more relevant example, ergot sclerotia of field-grown C. purpurea contain 1% to 2% 
ergot alkaloids by mass (5, 20).   
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The number of A. fumigatus conidia available in the air depends on the substrate 
and the environment in which the fungus is growing.  Under favorable conditions the 
fungus can sporulate prolifically.  A typical culture of A. fumigatus on PDA can yield 
~109 conidia per cm2 of culture surface area.  Viable A. fumigatus conidia per m3 of air 
range from 0 to 200 CFU in clean environments (27), to 107 CFU near composting 
facilities (12), to 1011 CFU near moldy hay or other stored organic materials (27).  
Considering an intake rate of 0.63 m3 of air per hr (32), a conidial ergot alkaloid content 
of 1% by mass, and no further ergot alkaloid production after inhalation of the fungus, 
ergot alkaloid dose would range from 3.7 pg per hr (at 200 CFU/m3), to 180 ng per hr (at 
107 CFU per m3), to 1.8 mg per hr (at 1011 CFU per m3).  An interesting point of 
reference is that an ingested dose of the illicit and highly active ergot alkaloid LSD can 
range from hundreds of ng to hundreds of µg (1), but based on US Drug Enforcement 
Agency data is frequently in the 20 to 80 µg range 
(http://www.nida.nih.gov/Infofax/lsd.html).  To inhale a comparable mass of A. 
fumigatus ergot alkaloids in one hour would require exposure to 107 to 1010 CFU per m3.  
Such high concentrations of conidia will be encountered only rarely.  A more practical 
issue to consider is whether there are potential health effects of a less remarkable nature 
(e.g., effects on depression, blood pressure, or sleep/wake cycles) associated with chronic 
daily doses of ergot alkaloids in the ng to µg range.  This issue has not been investigated.   
Toxicity of the particular ergot alkaloids associated with the A. fumigatus conidia 
has not been studied extensively, but the available data suggest that these mycotoxins 
have considerable biological activity.  Similar to other studied ergot alkaloids, 
festuclavine interacts with receptors for serotonin, dopamine, and α-adrenaline (7, 14, 24, 
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25).  Festuclavine and synthetic derivatives of festuclavine also are cytostatic in in vitro 
assays with several bacteria and mouse lymphoma cell lines (7, 8).  Moreover, 
festuclavine is unique among the naturally occurring ergot alkaloids in that it is directly 
mutagenic in the Ames test (15).  In the sole published animal study of fumigaclavine C, 
ingestion of relatively crude preparations of this ergot alkaloid greatly reduced feed 
intake of treated calves, and caused hemorrhagic enteritis of small and large intestines as 
well as patchy interstitial thickening of alveolar walls of the animals (3).   
Demonstration of the presence of ergot alkaloids at relatively high concentrations 
in or on conidia of A. fumigatus does not ipso facto indicate a role for the toxins in 
pathogenesis, other health effects, or any specific aspect of the biology of the fungus.  
However, it does raise interesting questions for further research.  Studies with ergot 
alkaloid-deficient mutants such as the dmaW-knockout strain described in the 
accompanying paper (4) should be useful for assessing the contribution of ergot alkaloids 
to virulence towards animals or potential contributions of the alkaloids to the ecological 
success of A. fumigatus.  Since minimization of the mass of a conidium appears to have 
been selected for in this fungus, the inclusion of alkaloids in quantities that exceed 1% of 
the mass of the conidium should have been selected against unless they provided some 
advantage to the fungus.   
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FIGURE LEGEND 
Figure 1: Chromatography of ergot alkaloids in untreated 80% methanolic extract and 
NaOH-treated methanolic extract of conidia of A. fumigatus WVU1943 cultured on PDA.  
Detection was by fluorescence with excitation and emission wavelengths of 272 nm and 
372 nm, respectively.  B = fumigaclavine B; F = festuclavine; A = fumigaclavine A; C = 
fumigaclavine C; dA = deactylfumigaclavine A; dC = deactylfumigaclavine C.   
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APPENDIX 2: Analysis of ergot alkaloids in spore only samples 
versus entire fungal (plate) cultures in the fungus, Aspergillus 
fumigatus 
INTRODUCTION 
Cultures of Aspergillus fumigatus consist of spores, conidiophores (asexual sporulation 
structures containing a stalked vesicle and a layer of phialides), and mycelia (vegetative 
growth).  Ergot alkaloids accumulate in high concentrations in or on spores of A. 
fumigatus, and production of ergot alkaloids is restricted to sporulating cultures of the 
fungus [(1, 3); Ch. 4, appendix 1].  Preliminary work indicated that extracts from spores 
contained a different ratio of the four major A. fumigatus ergot alkaloids than extracts 
made from plate cultures, containing all four cell types.  This observation raises the 
possibility that ergot alkaloids may be produced in cell types other than spores or in 
addition to spores.  The location of the production of alkaloids and the possibility of 
accumulation in other cell types has not yet been determined.  The purpose of this 
experiment was to compare ergot alkaloid accumulation in spore only extracts to extracts 
from plate cultures to gain insight into whether these alkaloids are present in other cell 
types of sporulating cultures. 
MATERIALS AND METHODS 
Ten plates of A. fumigatus isolate WVU1943 were cultured on potato dextrose agar 
(PDA) for two weeks at 37 ºC as previously described (3).  All manipulations were 
conducted in a Class II safety cabinet.   Agar plugs containing 50.3 mm2 of colony 
surface area from each of the ten A. fumigatus plate cultures were extracted in 1 mL of 
80% methanol as described by Coyle et al. (1).  To analyze spore only samples, plates 
were inverted, gently agitated and the abscised conidia that had collected on the inner 
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surface of the lid of each plate (n=10) were suspended in 1 mL of 80% methanol and 
extracted as above.  Aliquots were removed for ergot alkaloid analysis and enumeration 
of conidia for each sample.   
Ergot alkaloids present in each sample were identified and quantified by reverse-
phase HPLC analysis with fluorescent detection.  Peak identities were established based 
on work done by Panaccione and Coyle (3) together with elimination of those peaks by 
disruption of dmaW, the determinant step in the ergot alkaloid pathway [(2); Chapter 1].  
Quantification of ergot alkaloids was based on comparison of peak areas relative to an 
external standard as previously described (3).  Conidia present in dilutions of the initial 
methanol extracts were counted on a hemacytometer and visualized by light microscopy.  
Proportions of each individual ergot alkaloid were determined relative to total alkaloids 
in the sample.  Comparison of conidia-only extracts versus entire culture extracts was 
done by application of the Wilcoxon / Kruskal-Wallis (rank sum) test present in the JMP 
software package (SAS, Cary, NC).  This nonparametric test was chosen due to the 
unequal variance within some data sets.   
RESULTS 
Samples from the entire culture (and thus containing all four cell types) produced on 
average 3.26 fg of ergot alkaloids per conidium, whereas samples made up exclusively of 
mature, abscised conidia contained an average of 1.21 fg of ergot alkaloids per conidium.  
The difference in accumulation of total ergot alkaloids per spore is statistically significant 
(p=0.002)  
The proportion of festuclavine relative to total alkaloids extracted was 
significantly greater in plate extracts versus mature spore extracts (p=0.0002) (Fig.1).  
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The converse was true for the other three alkaloids, fumigaclavines B (p=0.0002), A 
(p=0.0025) and C (p=0.0002) (Fig.1). 
DISCUSSION 
It has been shown previously that ergot alkaloids accumulate in high concentrations in or 
on spores of A. fumigatus (3) and that production of ergot alkaloids is restricted to 
sporulating cultures (1).  The increase in total clavines per spore within samples 
comprised of all cell types versus only mature spores suggests that ergot alkaloids are 
also associated with other cell types within conidiating cultures.  The increase in 
percentage of festuclavine and the decrease in proportion of downstream fumigaclavines 
within these multicell-type culture extracts relative to mature spore extracts suggest that 
festuclavine may be produced prior to spore formation and that the final stages in 
fumigaclavine production occur preferentially in spores.  Whether there is discrete 
compartmentalization of these activities or simply an enrichment of enzymes for 
particular steps in different cell types has not been determined.   
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FIGURE LEGEND 
Figure 1:  Proportion of each individual ergot alkaloid relative to total alkaloids 
extracted.  A significant difference was found for each alkaloid using the nonparametric 
Wilcoxon / Kruskal-Wallis rank sum test.  Error bars represent standard error.  The insert 
represents a magnified view of proportions of fumigaclavine A and B. 
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